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1 INTRODUCTION     
Rabbit is a good model for research in reproductive biology and is widely used to 
develop embryo micromanipulation technologies because of its reproductive and 
physiological characteristics, such as relatively short gestation period, reasonable 
amount of milk production, and its developmental biology closely related to large 
farm animals more than that of rodents (mouse, rat and hamster). Additionally, 
transgenic rabbits were supposed to produce large scale of therapeutic antibodies for 
human clinical application. Until now, transgenic rabbits can be produced only by 
pronuclear microinjection (Hammer et al. 1985; Massoud et al. 1991; Fan and 
Watanabe 2003) or by the novel technique of chimeric somatic cell cloning 
(Skrzyszowska et al. 2006). Pronuclear microinjection, however, has a number of 
disadvantages including a low proportion of transgenic founders, mosaic founders, a 
low transgenic transmission rate and uncontrolled expression. Nuclear transfer (NT) 
with transfected somatic cells overcomes all those limitations, and allows a more 
controlled introduction of transgenes and, in some circumstances, make it  possible to 
preselect transgenic cell lines before the generation of cloned transgenic embryos by 
analyzing transgene integration sites (Schnieke et al. 1997; Bosze et al. 2003). 
 
Although several research groups have made large amount of work on rabbit cloning 
using somatic cells (Mitalipov et al. 1999; Dinnyes et al. 2001; Yin et al. 2002a), no 
live births were obtained in these sudies. The first live somatic cell cloned rabbit, 
which were derived from freshly collected cumulus cells, were obtained as a result of 
improved oocyte activation and synchronization of the recipients (Chesne et al. 2002). 
Later, cloned rabbits from fresh follicular cells, cultured fetal and adult fibroblast cells 
were obtained by several groups (Challah-Jacques et al. 2003; Li et al. 2006a; Yang et 
al. 2007). Success of rabbit somatic cell nuclear transfer (SCNT) is expected to 
resolve some of the difficulities of producing transgenic rabbits by pronuclear 
microinjection and allow studies on gene knock-in and knock-out strategies with a 
major potential impact on pharmaceutical and medical applications.  
 
The increasing amount of data on SCNT in different species suggests that cloning 
efficiency is closely related to incomplete or inappropriate epigenetic reprogramming 
of donor nuclei. The major players of epigenetic reprogramming are DNA 
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methylation and histone modifications including acetylation, methylation, 
phosphorylatioin, and ubiquitination of histone N-terminal tails (Bortvin et al. 2003; 
Shi et al. 2003). The delayed DNA demethylation, remethylation or absence of 
demethylation were observed in early bovine and rabbit embryos (Dean et al. 2001b; 
Shi and Haaf 2002). Aberrant histone methylation and acetylation associated with 
chromatin configuration (Nguyen et al. 2002) were found also in cloned bovine and 
rabbit embryos (Santos et al. 2003; Yang et al. 2007). As key chromatin 
modifications, di- and tri-methylated lysine 4 on histone H3 (H3K4m2/3), an 
epigenetic mark for transcriptionally competent euchromatin (Santos-Rosa et al. 2002; 
Schneider et al. 2004), and tri-methylated lysine 27 on histone H3 (H3K27m3), a 
mark for transcriptionally silent heterochromatin (Brinkman et al. 2006; Trojer and 
Reinberg 2007), might provide more insights into the relation between donor cell 
chromatin state and cloning efficiency. The latter modification is mainly found in so-
called facultative heterochromatin, which can switch between an active/euchromatic 
and an inactive/heterochromatic state, as in the case of the inactive X chromosome in 
female mammals as one of the most prominent examples of facultative 
heterochromatin (Plath et al. 2003; Silva et al. 2003). Due to their involvement in 
transcriptional regulation and a dynamic behaviour (Bhaumik et al. 2007) both 
chromatin modifications appear to be well suited to assess reprogramming effects 
during NT using donor cell types with different developmental potential.  
 
The aims of the present study were evaluation of the developmental potential of 
embryos cloned from different types of donor cells and their corresponding patterns of 
reprogramming hetero- and euchromatic histone modifications. For these purposes, 
we carried out NT with rabbit mesenchymal stem cells and adult fibroblasts. 
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2 REVIEW OF THE LITERATURE 
 
2.1 History of nuclear transfer in mammals 
The first concept of NT came from Spemann’s book, titled <Embryonic Development 
and Induction> (Spemann 1938). He suggested a radical method for testing nuclear 
potentiality by isolating the nuclei from progressively older embryos and transferring 
them into enucleated eggs, and the possibility of NT from a somatic cell to an 
enucleated egg. But at that time there was no way to perform this kind of experiment 
due to the technical limitations. 
 
2.1.1 Nuclear transfer using embryonic cells         
Nuclear transfer (NT) in mammals began in 1983 with the report from McGrath and 
Solter regarding the pronucleus exchange experiments in mouse embryos (McGrath 
and Solter 1983).  The NT technique developed by McGrath and Solter was most 
sophisticated with the use of micropipettes under a microscope. Two cytoskeletal 
inhibitors (cytochalasin B and colcemid) and a fusion procedure were used to treat 
embryos. Mouse NT experiments proved that the enucleated mouse one-cell embryos 
could only support the nuclei from one- or two-cell stage embryos to develop 
normally. However, transfer of nuclei from mouse eight-cell stage embryos into 
enucleated two-cell stage embryos resulted in normal blastocysts (Robl et al. 1986) 
and live mice (Tsunoda et al. 1987), supporting the suggestion that embryos 
reconstructed from mouse enucleated zygotes and nuclei of late stage embryos cannot 
develop to term. In 1986, Willadsen published a report on nuclear transplantation in 
sheep embryos, when donor cells from 8- and 16-cell embryos were fused with 
enucleated MII oocytes, and live cloned sheep were obtained for the first time 
(Willadsen 1986).  Since then, many animals have been cloned from nuclei of 
embryonic cells including cattle (Prather et al. 1987; Sims and First 1994), pigs 
(Prather et al. 1989), goats (Zou et al. 1995), rabbits (Stice and Robl 1988), monkeys 
(Meng et al. 1997). Scientists at that period believed that somatic cell nuclei cannot 
give rise to an entire organism, especially in mice, and only nuclei of embryonic cells 
possess a mysterious power called totipotency and can be reprogrammed in oocyte 
cytoplasm. 
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2.1.2 Nnuclear transfer using somatic cells 
The birth of sheep Dolly, the first mammal cloned from an adult somatic cell, has 
made a breakthrough in the field of cloning (Wilmut et al. 1997). This study not only 
confirmed that the genome may not undergo irreversible modifications, but also 
opened up a range of new ways to think about the questions that were of current 
interest, and provided the impetus to develop novel approaches for the genetic 
manipulation of mammals (Stewart 1997). 
After Dolly, 16 other mammalian species have been produced by SCNT including 
cows (Butler 1998; Cibelli et al. 1998a; Cibelli et al. 1998b), mice (Wakayama et al. 
1998), goats (Baguisi et al. 1999), pigs (Polejaeva et al. 2000), gaur (Lanza et al. 
2000), mouflon (Loi et al. 2001), domestic cats (Shin et al. 2002), rabbits (Chesne et 
al. 2002), horses (Galli et al. 2003), mules (Woods et al. 2003), rats  (Zhou et al. 
2003), African wildcats (Gomez et al. 2004), dogs (Lee et al. 2005a), ferrets (Li et al. 
2006c), wolves (Kim et al. 2007) and red deers (Berg et al. 2007). A large number of 
studies performed on different species tested various types of nuclear donors also with 
respect to their ability to be reprogrammed and to allow cloned embryos develop to 
term normally. It is generally accepted that relatively high efficiencies of somatic cell 
cloning in mammals can be achieved by using donor cells from the female 
reproductive system [e.g., cumulus/granulosa (Wakayama et al. 1998; Wells et al. 
1999), oviduct (Kato et al. 1998) and mammary gland cells (Wilmut et al. 1997; 
Ogura et al. 2000)]. Cloned animals have also been derived from fetal or adult 
fibroblast cells (Schnieke et al. 1997; Wakayama and Yanagimachi 1999; Kubota et 
al. 2000; Onishi et al. 2000) and male Sertoli cells (Ogura et al. 2000). But with other 
terminally differentiated cells, such as mature B and T cells or neuronal cells, first 
cloned mice were produced only via a two-step NT involving embryonic stem (ES) 
cell generation and tetraploid complementation (Hochedlinger and Jaenisch 2002; 
Eggan et al. 2004; Li et al. 2004). Later, cloned mice from natural killer T cells were 
produced using direct NT procedure (Inoue et al. 2005). The majority of cell types 
found in animals have yet to be tested by NT for their developmental potential. In the 
near future, cloning researches will focus on improvements of the techniques and on 
selection of the best nuclear donors for NT and genetic modifications. 
 
2.2 Donor cell sources 
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Developmental potential of a donor nucleus has a great impact on the efficiency of 
cloning by NT. So far, many undifferentiated and differentiated cells (or cell lines) 
have been proven to be the sources of donor cells for cloning. One aim for the near 
future is to establish cell lines, which can be cultured and genetically modified in vitro 
while their nuclei still maintain the ability to support development of cloned embryos 
to term. 
 
2.2.1 Embryonic cells 
Embryonic cells are isolated from early embryos, which are collected from the 
reproductive tract(s) of donor animals or obtained via in vitro maturation, fertilization, 
and culture.  In mice, donor cells from 4- and 8-cell embryos were transferred into 
enucleated 2-cell embryos resulting in live offspring (Tsunoda et al. 1987). Live mice 
were also obtained when cells from 4- and 8-cell embryos were transferred into 
enucleated MII oocytes (Cheong et al. 1993). In livestock (cattle, sheep, pig and 
monkey), there were reports on production of live offspring from nuclei of the 16-cell 
to morula stage embryos as well as from the inner cell mass (ICM) of blastocysts 
(Smith and Wilmut 1989; Loi et al. 1997; Wolf et al. 1998; Li et al. 2000; Mitalipov 
et al. 2002). It is worth to note that transfer of rabbit trophectoderm cells into 
enucleated oocytes resulted in a striking drop of blastocyst formation compared with 
the use of cells from ICM (Collas and Robl 1991). However, it has been demonstrated 
later in mouse that not only ICM nuclei but also trophectoderm nuclei of blastocysts 
have a developmental totipotency (Tsunoda and Kato 1998). 
 
2.2.2 Somatic cells and cell lines 
As mentioned before cloning researches should focus on selection of the best nuclear 
donors for NT and genetic modifications. Cumulus/granulosa cells (Wakayama et al. 
1998; Wells et al. 1999), oviduct cells (Kato et al. 1998), mammary gland cells 
(Wilmut et al. 1997; Ogura et al. 2000), fetal or adult fibroblast cells (Schnieke et al. 
1997; Wakayama and Yanagimachi 1999; Kubota et al. 2000; Onishi et al. 2000),  
male Sertoli cells (Ogura et al. 2000), mature B and T cells or neuronal cells 
(Hochedlinger and Jaenisch 2002; Eggan et al. 2004; Li et al. 2004), and muscle cells 
(Green et al. 2007)  have been successfully used as nuclear donors for SCNT.  
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Many strategies have been performed to modify donor cells for the purpose of 
improving the efficiency of NT, including using the fresh or in vitro cultured donor 
cells;  using somatic cells from donors of different ages (Tian et al. 2000; Kasinathan 
et al. 2001a; Xue et al. 2002), tissue origins (Galli et al. 1999; Miyashita et al. 2002; 
Wells et al. 2003), passages (Arat et al. 2001; Liu et al. 2001b) and culture conditions 
(Zakhartchenko et al. 1999); synchronization of the cell cycle stage of donor cells and 
recipient oocytes (Kasinathan et al. 2001b; Gibbons et al. 2002; Wells et al. 2003); 
and modifying epigenetic status of donor cells with chemicals (Jones et al. 2001; 
Enright et al. 2003; Yang et al. 2007). Alothough the efficiency of SCNT has been 
dramatically improved from the initial success rate of one live clone born from 277 
embryo transfers (Wilmut et al. 1997), none of the aforementioned efforts 
accomplished the common problems associated with this technique.  
 
2.2.3 Stem cells 
Stem cells are considered as the most promising cells today, because they have 
abilities to divide without limit to replenish other types of cells in the body as a 
backup for a sort of repair system. Stem cells include embryonic stem cells, 
embryonic germ cells, adult stem cells, and cancer stem cells. Two reports provided 
evidence that cloning efficiency using embryonic stem cells (ESCs) is five to ten 
times higher than that with somatic cells (Humpherys et al. 2001; Rideout et al. 2001). 
However, when hematopoietic adult stem cells at various differentiation states were 
used as donor cells for NT, terminally differentiated granulocytes were superior to 
less differentiated cells (Sung et al. 2006). It remains yet unclear whether somatic 
stem cells are better donors for NT than somatic cells or whether state of 
differentiation is a crucial factor affecting cloning efficiency.   
 
2.2.3.1 Embryonic stem cells 
Pluripotent stem cells include embryonic stem cells (ES) and embryonic germ cells 
(EG). Embryonic stem cells are isolated from morulae or the inner cell mass of 
blastocysts. The first mouse ES cell line were established by Evans and Kaufman in 
1981 (Evans and Kaufman 1981), and the first human ES cell lines were derived by 
Thomson in 1998 (Thomson et al. 1998; Thomson and Marshall 1998). Pluripotent 
stem cells or stem-like cells have been reported in many species including mouse 
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(Matsui et al. 1991), human (Shamblott et al. 1998; Mai et al. 2007), pig (Piedrahita et 
al. 1990a; Piedrahita et al. 1990b), horse (Saito et al. 1992), cow (Saito et al. 1992; 
Cherny et al. 1994), sheep (Thuchiya et al., 1994), mink (Sukoyan et al. 1993), rhesus 
monkey (Thomson et al. 1995), chicken (Pain et al. 1996), common marmoset 
(Thomson et al. 1996; Sasaki et al. 2005), rabbit (Fang et al. 2006), monkey (Byrne et 
al. 2007), dog  (Schneider et al. 2007) and cat (Yu et al. 2008). But the majority of ES 
cell lines from large animal hardly contributed to germ line. The reason might be that 
these the ES cell lines require a culture system which is different from the one used in 
the mouse, or there are factors or molecules which are yet unknown to control their 
differentiation. So they were named as embryonic stem-like cells in the most cases. 
The common essential characteristics agreed by many scientists of primate ES and EG 
cells should include derivation from the pre-implantation or post-implantation 
embryo, prolonged undifferentiated proliferation, and stable developmental potential 
to form derivatives of all three embryonic germ layers even after prolonged culture 
(Thomson et al. 1998).  
Due to the characteristics of ES cells (long term culture in vitro, while maintaining 
pluripotentcy), their genetic modification is possible. ES cells are a very effective tool 
to study the expression and function of genes both in vivo and in vitro, which had 
never been possible before. Usually, the mouse model is used as an example to 
explain how the gene targeting can be performed since mouse ES cell lines are the 
only available over the world. Any gene in the mouse genome may be inactivated 
(knock-out) or inserted at a specific locus (knock-in) by homologous recombination, 
and gene targeting events are then identified by PCR and Southern blot. After 
analysis, positive ES cells are reintroduced back to mouse blastocysts to produce 
chimeras. Finally, transgenic individuals will be produced, if the chimeras have 
transgenic cells in the germ line. 
Reports on the derivation of human ESC lines and EGSC lines have encouraged 
scientists to carry out more research on primate ES cells and to realise their potential 
applications in curing human diseases. If the cloning procedure is combined with 
human ES cell technology (called human therapeutic cloning), the immune 
compatibility and graft rejection in cell and/or tissue transplantation may be 
overcome. In this technology, the donor cells from patients themselves are transferred 
into enucleated human or animal oocytes to construct cloned embryos. The cloned 
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embryos are then cultured in vitro to produce blastocysts. ES cells are isolated from 
the ICM of these cloned blastocysts and then will be differentiated into different cell 
types and even tissues or organs for transplantation back to the patient when needed. 
Very recently, after adding four genes – Oct4, Sox2, cMyc, and Klf4 - into mouse and 
human fibroblasts, cells showed morphology and proliferation similar to ES cells 
under exposing in careful culture conditions (Takahashi et al. 2007a; Takahashi et al. 
2007b). When transplanted these cells into nude mice, teratomas containing various 
tissues of the three germ layers were produced. These “Induced pluripotent cells” (iPS 
cells) may help to resolve the difficulties of clinical applications of ES cells, including 
use of embryos and tissue/organ rejection after implantation. A quite new report 
showed that exogenous Oct4 together with either cMyc or Klf4 is sufficient to 
genetate iPS cells (Kim JB et al. 2008). However, this technique is at the beginning 
phase, still is so far to be perfect. For example, the exogenes are still necessary being 
added to permanently change the cell’s genetic material; the process of the adding 
genes to be silenced during differentiation is still not entirely understood; at least 
cMyc is cancer-causing gene. All those defects have not been yet  resolved.  In new 
reports where more types of cells were induced into iPS cells or iPS cells were 
differentiated into other cell lines (Narazaki G et al. 2008; Park et al. 2008). 
Therefore, the question whether iPS cells are too dangerous to treat patients remains 
to be answered.  
 
 2.2.3.2 Adult stem cells 
Adult stem cells, also know as somatic stem cells, are undifferentiated cells found 
throughout the body after embryonic development that divide to replenish dying cells 
and regenerate damaged tissues (Gardner 2002). As a main advantage, the use of adult 
stem cells in research and therapy is not controversial because adult stem cells are 
isolated from adult persons or children, that does not involve the destruction of an 
embryo (Zuk et al. 2002; Liu et al. 2005; Murrell et al. 2005). They have mainly been 
studied in humans and model organisms as mice and rats (Barrilleaux et al. 2006; 
Takahashi and Yamanaka 2006; Humphreys et al. 2008). 
Meschymal stem cells (MSCs) from bone marrow (BM) are on the leading edge 
because they are easy to expand in culture while maintaining their multilineage 
potential. MSC is the first type of adult stem cells that has been used for NT. Kato et 
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al. (2004) produced one healthy calf from a MSC. Usually, mesenchymal precursor 
mononuclear cells can be separated by centrifugation of bone marrow (BM) aspirates 
through a solution of Ficoll or Percoll. Such mononuclear cells have been isolated 
from the BM of many mammals, including laboratory rodents (Friedenstein et al. 
1976; Simmons et al. 1991), human (Pittenger et al. 1999), cats (Martin et al. 2002), 
dogs (Huss et al. 1995), pigs (Ringe et al. 2002) and rabbits (Wakitani et al. 1994). 
The MSCs from all species studied to date proliferate ex vivo as adherent fibroblast-
like cells, a feature that has been exploited to enrich MSCs from hematopoietic stem 
cells (HSC) that normally remain in suspension. They  are similar in that they are very 
rare, existing at an estimated frequency of about 1 in 100,000 bone marrow cells 
(Galotto et al. 1999). In cattle and pigs, even genetically modified MSCs retained the 
ability to differentiate as parental lines and supported  preimplantation development 
of cloned embryos at the rates similar to those obtained with non-genetically 
manipulated MSCs (Colleoni et al. 2005; Bosch et al. 2006). All these findings show 
that MSCs are easy to isolate and to culture in vitro, can be genetically modified and 
used for cloning by NT.  
 
                                              Blastomeres 
      Embryo                           
                                        
                                             Embryonic stem cells 
 
                                             Promordial germ cells                             Donor cells 
     Fetus                        
                                             Fetal fibroblast cells 
 
    Adult                                Different types of cells  
                                Fig. 1 Types of donor cells used for cloning 
2.3 Nuclear reprogramming of cloned embryos 
Despite the fact that the cloned animals derived from somatic cells have been 
successfully generated in 16 mammalian species, there are still so many unresolved 
problems with current cloning research, for example the low success rate of cloning  
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(less than 5%) (Tamada and Kikyo 2004), a high rate of abortion during early 
gestation and abnormalities in cloned animals. When and how these unexplained 
congenital malformations originate has been discussed in the progress of NT (Doherty 
et al. 2000; Dean et al. 2003). It is generally accepted that the defects are related to the 
reprogramming of specific nuclear activities in cloned animals. All these activities 
involve remodelling of the epigenetic features that overlay the gene sequences and 
find interpretation in new gene expression, but they do not relate to the change of the 
genetic sequences that comprise the genome (Surani 2001), that is epigenetic 
modification. Epigenetic modifications play vital roles in genome reprogramming 
during SCNT and include DNA methylation, histone modifications, telomere length 
regulation, X chromosome inactivation, genomic imprinting and other mechanisms.  
 
2.3.1 DNA methylation during embryonic development of normal (in vivo derived) 
and cloned embryos 
DNA methylation is the best characterized epigenetic mechanism and well known 
epigenetic regulator of gene expression. In mammals, between 60-70% of all CpGs 
(the 5'-cytosine residues at CpG dinucleotides) islands are methylated (Haines et al. 
2001). DNA methylation may affect the transcription of genes by physically impeding 
the binding of transcriptional proteins to the gene, thus blocking transcription, or by 
binding with proteins known as Methyl-CpG-binding domain proteins (MBDs) to the 
gene. 
The dynamics of DNA methylation in in vivo embryos must be understood if nuclear 
transfer is to succeed. It is widely agreed that, for example in mouse, normal fertilized 
embryos have global changes of DNA methylation (Dean et al. 2003). Fertilization 
initiates the decondensation of the sperm nucleus, resulting in the unwinding of the 
tightly packaged sperm DNA held in a unique, almost toroidal conformation by the 
sperm-specific protamines (Braun 2001). After fertilization, the paternal genome 
becomes actively demethylated in contrast to the maternal genome, which occurs to 
be passively demethylated during cleavage-stage divisions (Mayer et al. 2000). The 
global level of DNA methylation maintains at the lowest level in the morula and 
blastocyst stages, until sudden genome-wide de novo methylation (re-methylation) 
occurs by DNMT 3a and 3b (DNA methyltransferase) when embryos get implantation 
(Dean et al. 2001a).  
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Cloned embryos with methylation dynamics similar to normal embryos, have more 
chance to erase the tissue-specific DNA methylation pattern and to establish a new 
embryo-specific DNA methylation pattern on numerous genes successfully. A large 
proportion of cloned embryos showed abnormalities in the genome-wide DNA 
methylation levels and DNA methylation patterns on various repetitive sequences 
(Dean et al. 2001a), and high variability in DNA methylation levels among individual 
clones (Kang et al. 2001). One interesting observation was made in bovine cloned 
embryos when DNA methylation was undetectable in six out of nine spontaneously 
aborted bovine clones, but the methylation levels were normal in the clones that 
survived to adulthood (Cezar et al. 2003). In constract to this study, hypermethylation 
of DNA in fetal tissue, but not placenta, was linked to the over-growth phenotype of 
bovine SCNT and IVF fetuses (Hiendleder et al. 2004). A new interesting report 
showed that the methylation levels of IVF blastocysts were much more similar to NT 
and parthenogenetic blastocysts than to in vivo blastocysts (Bonk et al. 2008).  
DNA methylation defects might be attributed to the specific features of the somatic 
chromatin structure and/or defective regulation of DNA methyltransferases (DNMTs) 
(Tamada and Kikyo 2004). For example in mouse, cloned embryos expressed not only 
the somatic form of DNMT1 at abnormally high level, but also showed defective 
nucleo-cytoplasmic translocation of the oocyte form of DNMT1 (Chung et al. 2003). 
The defects in DNA methylation can be also caused by culture conditions of cloned 
embryos as in vitro culture reduced the methylation level in the regulatory CpG site of 
the H19 gene depending on the culture medium (Doherty et al. 2000).  
 
2.3.2 Genomic imprinting  
Genomic imprinting is an important mechanism in mammalian development by which 
some genes are activated depending upon their parental origin. In other words, it 
means that the activity of certain genes depends on whether the chromosome in which 
they are located is derived from mother or father. In several imprinted loci, imprinting 
control elements have been identified that are methylated on one of the parental 
copies of the gene. Imprinted genes frequently reside in clusters with genes expressed 
on opposite chromosomes being located adjacent to each other. Differential 
methylation of imprinted genes probably occurs during gametogenesis. For the 
gamete to acquire a sex-specific imprint, the previous genomic imprint must be 
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erased. It appears that methylation patterns are erased in the primordial germ cells of 
the midgestation mouse embryo.  
As demonstrated in uniparental embryos (McGrath and Solter 1984) and NT embryos 
derived from male primordial germ cells (PGCs) (Kato et al. 1999) or nongrowing 
oocytes (Kono et al. 1996), genome-wide imbalance in imprinted gene expression or 
its disruption results in postimplantation lethality. Early mouse nuclear transplantation 
studies showed that both paternal and maternal DNA was essential for the 
development of embryos in mammals (McGrath and Solter 1984; Surani et al. 1984). 
Gynogenetic embryos (containing two female pronuclei) are normal but small, and 
their extraembryonic tissue is very poorly developed. Androgenetic embryos 
(containing two male pronuclei), on the other hand, are quite retarded, whereas their 
extraembryonic tissue is well developed. The two parental genomes apparently 
function in a complementary fashion during development. Regions of paternal 
chromosomes are apparently pre-reprogrammed to direct proliferation of 
extraembryonic tissues, whereas certain maternal chromosomal regions are pre-
reprogrammed to direct development of the embryo body (Browder et al. 1991).  
Recently, viable mice have been generated from engineered bi-maternal embryos 
produced by the construction of oocytes from fully grown and nongrowing oocytes 
that contain double deletions in the H19 differentially methylated region (DMR) and 
the Dlk1- Dio3 intergenic germline–derived DMR (Kawahara et al. 2007). These 
results demonstrated that imprinted genes regulated by these two paternally 
methylated imprinting-control regions are the only paternal barrier that prevents the 
normal development of bi-maternal mouse fetuses to term. 
As demonstrated using conditional knockout technology (Kaneda et al. 2004), fetuses 
from Dnmt3a mutant females die in utero and lack methylation and allele-specific 
expression at all maternally imprinted loci examined; fetuses from Dnmt3a mutant 
males show impaired spermatogenesis and lack methylation at two of three paternally 
imprinted loci examined in spermatogonia. This provided the first evidence that 
DNMT3a is required for the establishment of both maternal and paternal imprints. 
However, both 102 Dnmt3b mutant males and 88 mutant females were found to be 
normal in the status of imprinting genes.  
Embryos produced using assisted reproduction technologies (ART) in human or by 
NT in several species showed widespread methylation defects in imprinted genes 
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(Humpherys et al. 2002; Mann et al. 2004). The abnormalities in the imprinted genes 
from the NT embryos may indicate susceptibility of the methylation imprinting in the 
somatic nuclei to the global methylation changes during early developemt (Tamada 
and Kikyo 2004).  
 
2.3.3 Histone modifications 
Histone modifications are associated with important biological processes such as cell 
proliferation, gene regulation, and DNA repair (Kothapalli et al. 2005).  
The modifications of the the H3 and H4 histones are considered as the key chromatin 
modficiations (Santos-Rosa et al. 2002; Schneider et al. 2004). For example in mouse, 
histone H3 and H4 are widespread deacetylated on several lysines at the metaphase II 
of the second meiosis, and similar events occur in somatic nuclei transferred into 
oocytes of the same stage (Kim et al. 2003). One study on fertilized bovine embryos 
showed that H3-K9 becomes hypoacetylated at the 4-cell stage and gradually 
hyperacetylated after the 8-cell stage, while in cloned embryos H3-K9 was found to 
retain hyperacetylation at 4- and 8-cell stages (Santos et al. 2003).  
Nearly 50% of cloned bovine and sheep blastocysts were aberrant in genome-wide 
patterns of both DNA methylation and histone acetylation and exhibited a high degree 
of methylation errors at specific loci (Shiota and Yanagimachi 2002; Han et al. 2003; 
Santos et al. 2003). Although more and more studies provide evidence for abnormal 
reprogramming of histone modifications following SCNT (Santos et al. 2003; Enright 
et al. 2005; Suteevun et al. 2006), the molecular mechanism(s) underlying the 
possible reasons of such failures are not yet well understood. However, the use of 
some chromatin modifying chemicals like the histone deacetylase (HDAC) inhibitors, 
trichostatin A (TSA) and sodium butyrate (NaBu), to treat donor cells can correct to 
some extent the process of nuclear reprogramming and increase cloning efficiency  
(Kishigami et al. 2006; Yang et al. 2007).  
 
2.4 Steps of NT  
Each step of NT affects the overall efficiency of this technique. Standardization of the 
steps is important to obtain consistent results, and improvements in technical steps 
will definitely affect both pre- and postimplantation development of the reconstructed 
embryos. However, due to a biological variation of the recipient oocytes and donor 
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cells, which is difficult to control, the efficiency of this technology is unpredictable 
and remains yet to be largely improved.  
 
2.4.1 Embryo reconstruction 
For embryo reconstruction by NT, enucleation (removal of the maternal DNA 
content) and introduction of a donor nucleus into a recipient cytoplasm must be 
performed using a variety of methods. The conventional method is, firstly, to 
enucleate the oocyte to generate a cytoplastst with a sharp pipette, and secondly, to 
transfer the donor nucleus under the zonae pellucida. Because mouse oocytes are too 
easy to be damaged by injection pipette, Piezo-driven enucleation device was used to 
improve the penetration of very flexible zonae pellucidae (Wakayama et al. 1998). 
The first cloned rats were produced only by using a Piezo-driven injection of somatic 
cell nuclei (Zou et al. 2003). In farm animals, Piezo-device has not been adopted as 
enucleation can be successfully achieved without it. Whatever, injection of a cell 
nucleus directly into the cytoplasm using Piezo device may improve nuclear 
reprogramming allowing better access of cytoplasmic factors to the nuclear DNA.   
NT can be also performed by so-called hand-made cloning (HMC) without the use of 
a manipulator unit (Vajta et al. 2001). HMC comprises of bisecting oocytes, 
seclecting those half cytoplasts that do not contain the metaphase plate and adhering 
two half cytoplasts together with one donor cell by using phytohaemagglutinin 
(PHA), a cell-aggultinating lectin glycoprotein (Sharon and Lis 1989), followed by an 
electropulse. Birth of cloned calves, pigs and horse from HMC were reported by 
several groups (Vajta et al. 2004; Hall et al. 2006;Kragh et al. 2004; Lagutina et al. 
2007). 
Using chemicals to assist enucleation can be also one of the approaches to improve 
embryo reconstruction by NT. The successful chemical enucleation of mouse oocytes 
have been reported using demecolcine (colcemid) to induce a membrance protusion 
containing a condensed chromatin mass in oocytes, which was subsequently 
mechanically removed (Baguisi and Overstrom 2000). Cloned pigs and rabbits were 
produced using chemically assisted enucleation (Yin et al. 2002b; Yang et al. 2007).   
Serial NT (comprising of two or more NT steps) was also designated to improve 
cloning efficiency. Briefly, the first NT is carried out according to conventional 
methods. In the second round, a blastomere (karyoplast) from 2- to 8-cell cloned 
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embryos was introduced into enucleated zygotes or 2-cell stage embryos (Kwon and 
Kono 1996). This second round of NT was considered to help the somatic cell–
derived pronuclei of the cloned embryos reprogramming into a naturally fertilized 
pronuclear stage cytoplast, from which the pronuclei were previously removed. In 
pigs (Polejaeva et al. 2000), mice (Amano et al. 2001; Ono et al. 2001) and cattle 
(Hall et al. 2006), serial NT was successfully applied.  
 
2.4.2 Cell cycle synchronization between donor cells and recipient oocytes 
The mature metaphase II (MII) oocytes are considered to be the most appropriate 
recipients for cloning by NT. These oocytes are at the stage MII of meiosis. When a 
donor cell is fused with or directly injected into the enucleated oocyte, and the 
reconstituted oocyte is activated, the cloned embryo starts its first cell division. 
During very early events in the reconstructed embryo the co-ordination of the cell 
cycles of a donor nucleus and a recipient oocyte plays a crucial role.  
A review by Campbell et al (1996) summarised the relation between the cell cycles 
stages of donor cell and recipient cytoplasm in nuclear transplantation. When nuclei, 
regardless of their cell cycle stage, were transferred into MII oocytes, they underwent 
nuclear envelope breakdown (NEBD) and premature chromosome condensation 
(PCC), and then started DNA synthesis after reformation of the nuclear envelope. 
Theoretically only nuclei in G1 phase could support the development of cloned 
embryos to term when transferred into enucleated MII oocytes, and nuclei in G2 or S 
phases would produce chromosome abnormalities in cloned embryos which most 
likely fail to develop (Campbell et al. 1996; Wilmut et al. 1997). The cell cycles of 
donor nucleus and recipient cytoplasm are important factors for the successful 
development. 
Use of nuclei in M phase of cell cycle in mouse nuclear transplantation appeared to be 
very successful. A set of sextuplet mice from a single four-cell stage embryo was 
produced (Kwon and Kono 1996). When nuclei at M phase are transferred into MII 
oocytes, the cell cycles of both nucleus and cytoplasm are perfectly matched. After 
activation, the reconstituted embryos cultured in vitro in a medium without 
cytochalasin B (CB), would expell a polar body to become normal diploid embryos. 
The advantages of usage of M phase nuclei are: a) synchronisation is simple and 
successful by applying inhibitors of tublin polymerisation, such as nocodazole and/or 
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thymidine, which are not toxic to embryo development; b) it can avoid the delay of 
chromosome formation in cloned embryos after donor cell transfer. Two mice were 
cloned from metaphase embryonic stem cell nuclei (Zhou et al. 2001). 
Wilmut and Campbell (1998) argued that serum depletion of a cell culture medium to 
achieve the quiescent phase of the donor cell cycle was a key factor to clone the first 
cloned sheep “Dolly”. Quiescense is achieved by culturing the cells in vitro in a 
defined medium with 0.5% or less FCS for a few days (serum starvation). But another 
group headed by Robl and Stice (Cibelli et al. 1998b) produced three cloned calves 
from non-quiescent cycling foetal fibroblast cells. Since the birth of Dolly, thousands 
of cloned animals have been produced in different species with or without serum 
starvation thus suggesting that the quiescent state of a donor nucleus is not a critical 
prerequisite for successful cloning by NT.  
 
2.4.3 Activation of reconstructed embryos 
In normal development, a sperm activates an oocyte, i.e. triggers the release from the 
meiotic arrest and subsequent development. It is generally accepted that the sperm 
induces oocyte activation by generating temporary transient increases in the 
intracellular free Ca2+ concentration, which in mammals takes the form of a series of 
repetitive Ca2+ transients that last for several hours (Whitaker and Swann 1993).     
The most commonly used method for activation in nuclear transplantation at the early 
days was applying the electric stimulation to the reconstructed embryos. The electric 
stimulation, which also induces the fusion between the donor cell and recipient 
cytoplasm, results in the formation of temporary pores in the plasma membrane 
allowing an exchange of extracellular and intracellular Ca2+ and macromolecules to 
produce only a single Ca2+ transient (Rickords and White, 1992). Clearly, this 
demonstrates that the intracellular Ca2+ flux associated with fertilisation has not been 
reproduced by simple electric stimulation procedure. This might partially explain why 
most of the cloned embryos fail to develop normally. 
Another method of activating reconstructed embryos along with elevation of Ca2+  
using electric pulse or some chemicals is subsequent treatment with compounds that 
affect protein kinase activity. 6-dimethylaminopurine (6-DMAP) is a protein kinase 
inhibitor (Susko-Parrish et al. 1994) and cycloheximide (CHX) is a protein synthesis 
inhibitor (Presicce and Yang 1994), both of them could reduce the synthesis of cyclin 
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B in the embryos. Cyclin B is a component of metaphase promoting factor (MPF). In 
order to maintain adequate levels of active MPF, it must be continually synthesized. 
With the decline of MPF activity, the reconstructed embryos enter the first inter-phase 
(Collas et al. 1992; Alexander et al. 2006). Experiments have proved that better 
activation and development of cloned embryos can be obtained if two or more 
activation methods are combined together (Alexander et al. 2006).   
 
2. 5 Applications and prospects of cloning 
 
2.5.1 Identical animals for research and clinic trials 
In research and clinic trials, the biggest problem is that the animals used are not 
genetically identical, which often produces a range of different or in some cases false 
results. In 1997, the SPF (specific pathogen free) animals (especially mice) have been 
available (Jacoby and Lindsey 1997). Because of their SPF status, they produce better 
results in experiments, but the results are still not consistent. Although identical twins 
are produced naturally or can be created by embryo splitting, the number is limited for 
scientific research. Cloning mat pave the way to produce large numbers of genetically 
identical animals for scientific research and clinic trails. Nevertheless, epigenetic 
differences among clones from the same genotype may cause problem. 
 
2.5.2 Production of a large flock of the same quality and genetic background farm 
animals (reproductive cloning) 
High quality farm animals are rare and very important for consumers and farm 
industry. Cloning can reproduce the animals with unique genetic background at a 
large scale. Perceived benefits of the cloning of farm animals include a range of 
possibilities within basic research, biomedical research and agricultural production. 
Applications within the areas of improving animal welfare, the recreation of extinct 
species, and the conservation of endangered and threatened species are also worth 
mentioning (Vajta and Gjerris 2006). 
 
2.5.3 Rescue of endangered species 
Expanding populations of endangered species for which breeding programmes or the 
availability of oocytes are limiting, is one of the most exciting potential opportunities 
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provided by SCNT. Approximately 100 species become extinct a day around the 
world. Extinction threatens 11% of birds, 25% of mammals, and 34% of fish species 
(Porter 2000). Cloning may offer a strategy for rescuing those endangered species. 
Lanza et al. (2000) reported several pregnancies after transfer of somatic cells from a 
gaur bull (Bos gaurus), a large wild ox on the verge of extinction, into enucleated 
oocytes from domestic cows. The gaur nuclei were shown to direct normal fetal 
development, with differentiation into complex tissue and organs, even though the 
mitochondria DNA (mtDNA) within all the tissue types evaluated was derived 
exclusively from the recipient bovine oocytes. This study illustrates both the viability 
and the likely limits of such an approach. Successful production of cloned progeny 
has been achieved mainly in closely related species, for example Ovis genera and Bos 
(Loi et al. 2001; Meirelles et al. 2001; Arat et al. 2003). It appears development 
efficiency of intra-species cloning tended to be higher than that of inter-species 
cloning (Li et al. 2006b), and the more species, the donors of cells for NT and 
recipient oocytes, close to each other the more greater blastocyst development in vitro 
(Loi et al. 2007). NT using more divergent combinations of donor cells and recipient 
oocytes lead to early developmental arrest (Arat et al. 2003), as indicated by the facts 
that only 6.2% of cloned embryos developed beyond the 8-cell stage when mouse 
embryonic fibroblasts were transferred into bovine oocytes, and 3% and 2% 
blastocyst rates were reported when transferring donor cells from marbled cats or 
domatic cats into rabbit oocytes, respectly (Thongphakdee et al. 2006). It is possible 
that further refinements in culture systems and NT steps could facilitate the 
development of inter-species clones to term.  
 
2.5.4 Genetically modified animals for bioreactor factories and cancer research 
One of the major applications of SCNT is production of transgenic cloned animals 
from donor cells whose genome has been modified (Table 1). There are a number of 
methods for the generation of transgenic animals, including pronuclear microinjection 
(Brinster et al. 1985), retroviral vectors (Chan et al. 2001), electroporation (Zou et al. 
1995) sperm carrier of introducing a foreign gene(s) into the genome of donor cells 
(Shemesh et al. 2000). Lentiviral vectors and small interfering ribonucleic acid 
(siRNA) technology are also becoming important tools for transgenesis (Clark and 
Whitelaw 2003). Genome modifed animals have numerous attractive applications in 
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biomedicine such as production of recombinant human proteins, nutriceutical 
production, blood replacement, xenotransplantation, and genetic models for human 
disease as well as for improving livestock production traits including disease and 
disease resistance, more efficient feed conversion, and milk composition for 
manufacturers. 
The first transgenic mammalian clones expressing human factor IX were two lambs 
produced at the Roslin Institute by using transfected fetal fibroblast cells (Schnieke et 
al. 1997). The cultured cells were transfected with DNA constructs composed of the 
coding sequences for neomycin resistance and human clotting factor 1X placed 
downstream of the promoter sequence for ovine β-lactoglobin. The cells were then 
exposed to G418, killing all cells except those expressing neomycin resistance. The 
surviving cells having integrated both the gene for clotting factor 1X and the promoter 
sequence were used for NT. The promoter sequence was included to ensure that the 
clotting factor gene would function specifically in the mammary gland of the 
transgenic sheep to be produced. The surviving transgenic sheep, Polly, has indeed 
produced milk containing human clotting factor IX (Wilmut and Campbell 1998). 
Since then, transgenic clones of calves, goats, pigs, mice and additional sheep were 
produced from transgenic fetal cells. Three cloned calves expressing the neomycin 
resistance transgene (Cibelli et al. 1998b) and three cloned goats containing the 
human antithrombin III gene (Baguisi et al. 1999) were generated in the studies when 
the respective genes were inserted at random into the genome of the donor cells. 
Later, a gene targeted sheep was created in Edinburgh (McCreath et al. 2000). Human 
a1-antitrypsin (AAT) under beta-lactoglobulin (BLG) promoter control was 
homologously integrated into the a1(I) procollagen (COL1A1) locus by cloning. One 
lamb has been induced to lactate a favorable quantity of the human protein in her 
milk. This report showed for the first time that gene targeting in farm animal can be 
achieved by transfecting fetal fibroblasts, selecting them for homologous 
recombination, and using the targeted cell clones for nuclear transfer (Fig. 2). As there 
were no reliable ES lines in large domestic animals, cultured fetal cells have been 
used for inserting the respective transgenes.  
Fortunately, mouse ES cell lines were established in 1981 (Evans and Kaufman), and 
the production of transgenic mice through the use of ES cells has offered a powerful 
method to study gene expression and gene function (Pirity et al. 1998). Wakayama et 
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al. (Wakayama et al. 1999) obtained 26 cloned mice from late passages of an 
established ES cell line with a success rate of 8% based on the number of cloned 
embryos transferred to surrogate mothers. Subsequently, after integrating a tet-
transactivator gene (rtTA2 SD) into the ROSA26 locus of ES cell lines via 
homologous recombination, a single cloned mouse was produced and developed into 
a fertile mouse expressing the transgene (Rideout et al. 2000). Although the 
proportion of transgenic newborns was low, the success was remarkable. A few 
founder clones would be that necessary minimum to start a breeding programm for 
transmitting and expressing the respective transgenes. Although, the production of 
large transgenic animals has been hampered by the lack of their respective ES cells, 
production of recombinant human proteins in the milk of transgenic dairy animals 
offers a safe, renewable source of commercially important proteins that cannot be 
produced as efficiently in adequate quantities by other methods. The first three 
transgenically produced recombinant proteins (Human factor VIII, Anti-thrombin III 
and Erythropoietin) are in the phase III of clinical trials (see table 2).  
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Table 1 Transgenic mammalian clones 
Species Transgene Offspring/embryos 
transferred No.(%) 
Reference 
Sheep human clotting Factor IXa 
human alpha 1-antitripsin a,b 
3 (7) 
14 (3) 
Schnieke et al. 1999 
McCreath et al. 
2000 
Cattle neomycinr 3 (11) Cibelli et al. 1998 
Goats human antithrombin IIIa 3 (3) Baguisi et al. 1999 
Mice Tettransactivator b,c 1 (14) Rideout et al. 2000 
Pigs human complement CD59 
(hCD59) 
-   (-) Imaizumi et al. 2000 
Cattle r28M  11(77) Grosse-Hovest et 
al. 2004  
Rabbits Tg(Wap-GH1)  24(163) Skrzyszowska et al. 
2006 
a: Integrated into fetal cells; b: embryonic stem cells; c: via gene targeting; r: resistance 
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Table 2.  Partial list of medical-valuable proteins produced via SCNT 
 
Proteins Main functions Application Market value 
(Million dollar 
/year) 
ATIII Regulating blood 
clotting 
Surgical operation and 
ATIII mutation disease 
200 
Human serum 
albumin 
Artificial human 
blood 
Transfusion 1500 
Beta-Interferon Increasing immune 
defence 
Cancer and immune 
deficiency diseases 
500 
Calcitonin Bone metabolism Osteoporosis 1000 
Insulin Sugar metabolism Diabetes 1500 
Human growth 
hormone 
Body height Dwarfism 1000 
 
 
 
 
 
 
 
   
Fig. 2   Gene targeting of Beta-lactoglobulin  
A. Genomic map of beta-lactoglobulin,            in   indicated exons;  
B. Gene target construct, NEO (neomycin) is a selective marker gene. 
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The deletion or mutation of any gene of interest in mammal is becoming into the most 
exciting field, which transforms the landscape of mammalian biology research. 
Knock-in or knock-out animal models provide valuable research tools for dissecting 
the biochemical pathways responsible for neoplasia and for testing new therapeutic 
agents. The first knock-out pigs were produced at 2002 (Lai et al. 2002). These 
authors disrupted the sequence of the α-1,3-galactosyltransferase  gene (GGTA1) in 
fibroblasts using homologous recombination, then transferred these cells into 
enucleated oocytes, and finally obtained four knock-out pigs. The important practical 
significance of this research was to facilitate studies on xenotransplantation of pig 
organs to humans, as elimination of terminal α-1, 3-galactosyl epitopes from the pig 
was expected to resolve the problem of hyperacute and delayed vascular rejection. 
Another useful model is BHD (Birt-Hogg-Dube) knock-out mouse. Because renal 
cystadenocarcinoma nodular dermatofibrosis (RCND) in dogs (Lium and Moe 1985; 
Lingaas et al. 2003) and renal tumors in the Nihon rat (Okimoto et al. 2004) occur in 
animals that inherit a germline mutation in the corresponding BHD homolog, these 
naturally occurring animal models may harbour additional genetic changes that could 
confound studies of the functional consequences of BHD inactivation. A genetically 
engineered mouse model is necessary to provide a "clean" system to pursue functional 
studies of folliculin (FLCN). The targeted BHD knock-out  mouse model was 
established by injection the BHD targeted embryonic stem cells  into mouse 
blastocysts to produce chimeras (Baba et al. 2008). As the proof of the great scientific 
achievement in this field, three scientists, Mario Capecchi, Martin Evans, and Oliver 
Smithies, have been honoured by Nobel medicine prize at 2007 for significant 
contribution in establishment of the knock-out technology. 
In summary, cloning with transgenic somatic cells offers similar advantages as with 
mouse ES cells in the production of transgenic animals because somatic cells can also 
be cultured, genetically modified and maintained in vitro over a long period and still 
are able to be reprogrammed to develop to term.  
 
2.5.5 Cloned pigs for tissue and/or organ transplantation 
The transplantation of organs from other species into human is considered to be a 
potential solution to the shortage of human donor organs. Organ transplantation from 
pig to human, however, results in hyperacute injection. Transgenic, gene targeting and 
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cloning technologies could be used to produce strains of pigs, which are labelled with 
human immune marker, or from which endogenous genes are deleted to avoid 
hyperacute rejection and acute vascular rejection.  
The key enzyme responsible for the rejection is the GGTA1 gene, which has opened 
up several novel therapeutic approaches to prevent hyperacute vascular rejection 
(Joziasse and Oriol 1999). As mentioned before, the first GGTA1 knock-out pigs 
were produced at 2002 (Lai et al. 2002). Recently, recloning method for production of 
GGTA1 knockout pigs resulted in a higher pregnancy rate compared to that using 
direct NT (50 vs. 20%, respectively) (Fujimura et al. 2008). Molecular cloning, and 
expression in vitro of GGTA1 cDNA, has allowed the development of strategies to 
induce immune tolerance, and deplete or neutralise the natural xenoreactive antibody.  
      
2.5.6 Therapeutic cloning 
The aim of therapeutic cloning is to produce human embryos not for generating 
cloned human beings, but rather to harvest stem cells that can be used to study human 
development and to treat disease. Using SCNT, “personalized” ES cell lines could be 
obtained from the cloned blastocysts (ntES). Such cell lines would offer the following 
advantages: a) minimize the risk of tissue rejection after autologous transplantation; 
b) allow for the correction of genetic defects; and c) serve as cell culture models to 
study pathomechanisms and disease progression. The ntES cells, which for the fist 
time were created in mice, had functions similar to those of fertilized embryo–derived 
ES cells (Wakayama et al. 2001). Later, when comparing the transcriptional profiles 
of multiple ntES cell lines to ES lines, Brambrink et al.  found that the molecular 
characteristics of the lines were largely indistinguishable (Brambrink et al. 2006), 
suggesting that ntES cells are similar to ES cells, both in genetics and functions.  
In 2001, scientists from Advanced Cell Technologies (ACT), a biotechnology 
company in Massachusetts, announced that human embryos had been cloned for the 
first time as the purpose of advancing therapeutic research. The research was carried 
out with eight woman oocytes, three began dividing, and only one was able to divide 
into six cells before stopping, finally no ntES cell lines have been derived. The results 
were limited in success. Still, derivation of ntES cell lines from humans has not yet 
been successfully performed. The field took a major step backward on the 
announcement that the Korean scientist Hwang and his group had fabricated data 
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outlining the derivation of ntES cell lines from humans (Lee et al. 2005a). Sometime 
later, their embryos were clearfied as parthenotes. Presently, there is a report on 
development of human nuclear transfer embryos to the blastocyst stage, but no 
generation of ntES cell lines (French et al. 2008). Two major limitations to the 
success in this research include the small numbers of human oocytes available and the 
low efficiency of successful nuclear reprogramming.  
A recently describled technique of isolating ES cells from the 8-cell embryos may 
improve the efficiency of ES and ntES cell derivation. For example, in both mouse 
and human studies, researchers at Advanced Cell Technologies generated ES cell 
lines from single-cell biopsies of the 8-cell embryos (Chung and Becker 2006; Chung 
et al. 2006; Klimanskaya et al. 2006). This technique may soon allow for more 
efficient ntES cell line isolation because nuclear transfer embryos increasingly fail to 
develop as culture time lengthens, and this technique also allows for the generation of 
ES or ntES cell lines without significantly damaging the remaining embryo from 
which the single cell originated.  
There are technical and ethnic difficulties in obtaining human stem cells and using 
them for therapeutic purposes. In ten to twenty years’ time, the technical difficulties 
might be overcome. But the ethical questions may hinder the development of this 
technology, and we have to weigh out between saving lives or having good lives and 
ethical concerns. Embryonic stem cells are not genetically matched to the patients and 
therefore not immuonologically competent for cell therapy.  Only stem cells from the 
same patient are safe in the respect of avoiding the use of drugs to suppress immune 
response. Adult stem cells probably will the better choice in therapeutic purposes, but 
have a limited multilineage differentiation potential.  
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3 MATERIALS AND METHODS 
All chemicals were purchased from Sigma Chemical Co. (St. Louis, MO), unless 
otherwise indicated. 
 
3.1 Animals 
Animal experiments were approved by the Regierung von Oberbayern (Az 209.1/211-
2531-5/01). 
Mature ZIKA rabbits were obtained from the Agrobiogen Company (Germany); and 
Ali/Bas rabbits were donated by the THP Company (Germany).  
Rabbits were maintained in 70 x 70 x 60 cm cages. They received deukanin energie 
pellets (Deuka, Etteldorf,  Cat. No. 76320) and water daily ad libitum and hay. 
 
3.2 Collection of recipient oocytes 
Oocytes were collected from superovulated ZIKA® rabbits by injection of 100 IU 
pregnant mare’s serum gonadotrophin (PMSG, Intervet Deutschland GmbH, 
Unterschleissheim) intramuscularly and 100 IU human chorionic gonadotrophin 
(hCG, Intervet Deutschland GmbH) intravenously 72 h later. Mature oocytes were 
flushed from the oviducts 15–16 h post-hCG using pre-warmed in 25°C mPBS 
(phosphate-buffered saline supplemented with 4 mg/ml BSA), then the oocyte-
cumulus complexes were incubated in 0.5% hyaluronidase in M199 (Hepes buffered- 
medium 199 supplemented with 10% FCS) for 15 min in 5% CO2 and 38.5°C 
incubator. The cumulus cells were removed by gentle pipetting. 
 
3.3 Induction of MII metaphase protrusion and enucleation  
Denuded oocytes were treated with 0.6 µg/ml demecolcine in M199 between 20 min 
to 2 h (Yin et al. 2002a; Yin et al. 2002b). The resulting MII metaphase protrusion 
with little underlying cytoplasm was removed in M199 supplemented with 7.5 µg/ml 
CB and 0.6 µg/ml demecolcine. Enucleated oocytes were washed and kept in M199 in 
an incubator for later use as recipient cytoplasts. 
 
3.4 Preparation of donor cells: MSCs and RAFs 
 
3.4.1 Establishment of primary culture of MSCs and RAFs  
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3.4.1.1 Isolation and culture of MSCs 
a)  Femurs of the rabbits (aged between 4~8 week old) were removed and cut under 
sterile conditions.  
b)  Bones   were   washed   3   times   with  Ca2+- and  Mg2+- free   PBS   containing 
     100 IU/ml penicillin and 100 µg/ml streptomycin, and then muscles covering the 
      bones were removed. 
c)  Bones were flushed with PBS containing 250UI/ml heparin to collect bone marrow  
(BM) (~20ml).         
d)  BM were put on the surface of Percoll (density, 1.077) in 2:1 and centrifuged at 
800 g for 20 min at room temperature.  
e)  The mononuclear cells were recovered with pipette from the opaque interface and 
washed twice with culture medium, MesenCult Medium (Basal Medium for 
Mouse Mesenchymal Stem Cells (Cat: 05501) and Supplement Medium for 
Mouse Mesenchymal Stem Cells, StemCell Technologies, Vancouver, Canada) 
(MSC medium).  
f)   Cells were cultured in MSC medium in a humidified atmosphere of 5% CO2 in air 
at 37°C.  
g) After 24h culture, unattached cells were washed off during medium exchange. 
Adherent fibroblast-like cells were expanded for 7~10 days with medium 
replacement every third day. Cells were passaged after treatment with 0.05% (w 
⁄v) trypsin ⁄EDTA and reseeded in 1:2. 
 
3.4.1.2 Isolation and culture of RAFs 
a)  Small ear skin biopsies of young rabbits were cut under sterile conditions.  
b)  The tissues were washed three times with PBS and hairs were removed by sterile 
scissors. 
c)  Tissues were minced into 1x1 mm small pieces by sharp-tip sterile scissors and 
distributed on the bottom of 25-cm flasks filled with 1 ml DMEM/F12 
supplemented with 10% FCS and penicillin/streptomycin (100 IU/ml penicillin 
and 50 µg/ml streptomycin). The flasks were turnovered and put in an incubator 
for 1-3 hours at 37°C with 5% CO2 in air with saturated humidity. 
d)  Flasks were turned down and added 8 ml more culture medium. 
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e)  The culture medium was changed when it is necessary. Growth of the cultures was 
monitored with an inverted optical microscope. 
f)  The cells were trypsinized when the cell monolayer was formed about 90%, and 
then diluted in complete culture medium, distributed into 35-mm dishes and 
incubated at 37ºC. 
3.4.2 Cell freezing  
a)   Confluent MSC and RAF cells were trypsinized for 1-2 min. 
b)   Culture medium (1 ml) was added into dishes to stop enzyme treatment.  
c)   Cell  suspension was transferred into 15-ml Falcon tube and centrifuged at 140 g       
for 5 min. 
d)   Supernatant was sucked off and pellet was resuspended in 2 ml culture medium. 
e)   Cell numbers were counted by haemocytometer using the following protocol: 
• Place a drop (10 - 20 µl) of well-mixed cell suspension at each notch. Add 
drop all at once to ensure even distribution of cells.  
• Count the number of cells in the 1 mm square (= 0.1 µl). Count eight 1mm 
squares. Select the 4 corner squares on the 2 grids on the haemocytometer. 
Calculate the average. Multiply by 1 X 104 to determine the number of cells 
per millilitre. 
f)    Medium was removed  by pippet. 
g)  Cells were re-suspended in cold freezing media (10% DMSO, 90% FCS) in a 
density  1x106 cells/ml. Cells were kept chilling while working. 
h)   Cell suspension (1 ml) was placed in a cryogenic tube, labelled and stored first for  
      30 min at 4°C, then for 2 h at –20°C, and finally overnight at -80°C. 
i)    Next day, cells were placed in liquid nitrogen or at -80°C. 
 
3.4.3 Cell thawing 
Frozen cells were fast thawed by adding prewarmed (37°C) complete cell culture 
medium with gentle pipetting. Then cells were pelleted by centrifugation at 140 g for 
5 min in  5 ml volume, seeded into 35-mm cell culture dishes. 
 
3.4.4 Preparation of cells for NT  
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Confluent MSCs and RAFs were washed with Ca2+- and  Mg2+- free   PBS  twice, 
trypsinized for 1 min, and then collected by centrifugation at 140 g for 5 min in 5ml 
M199. Finally, the cells were resuspended in M199 for NT. 
 
3.4.5    Characterization of MSCs and RAFs 
3.4.5.1   In vitro life span of MSCs and RAFs  
Primary isolated MSCs and RAFs were seeded into 35-mm dishes at a density of 
1x104 cells/ml in a medium for Mouse Mesenchymal Stem Cells or in DMEM/F12. 
The cells were passaged and counted with a haemocytometer as described before until 
they reached replication senescence, during which cell morphology considerably 
changed and proliferation capacity decreased. The number of population doublings 
were calculated by formula PD = Log10(N/N0) X 3.33. 
 
3.4.5.2 Karyotype analysis 
a)  80-90% confluent RAFs and MSCs on a 35-mm dish were split as 1:2, and then 
cultured for another 24 h. 
b)  Demecolcine was used to synchronize cell cycle with a final concentration of 0.1 
µg/ml in culture medium. Cells were cultured for another 150-180 min under 
treated with demecoline. 
c)  Culture medium was removed to a 15-ml conical tube. 
d)  Adherent cells were washed once with Ca2+- and Mg2+- free PBS, and medium 
was collected into the same 15-ml conical tube as in step c). 
e)  Cells were treated with 0.05% trypsin/EDTA solution for 1-2 min, and then 2 ml 
washed with culute medium. 
f)   Detached cells were collected into the same 15-ml conical tube as in step c). 
g)   Cells were pelleted by centrifugation at 140 g for 10 min. 
h)  Medium was carefully removed leaving about 0.5 ml supernatant in the tube, and 
the pellet was gently resuspended by flicking the tube with fingers.  
i)  The cells were resuspend in the remaining medium and approximately 2 ml  
prewarmed (37°C) 0.075 M KCl (potassium chloride in bidistilled water) was  
slowly added. Then an additional 8 ml KCL was added for a total of 10 ml and 
mixed well.  
j)   The suspension was incubated for 15 min at 37°C in the water bath. 
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k)  A few drops of freshly prepared fixative solution (3:1 methanol/acetic acid, Rothe) 
were added to the suspension to stop reaction, re-cap the tube, and inverted to 
mix. 
l)   After centrifugation as step g), 0.5 ml of the supernatant was left in the tube. The 
cells were resuspended and fixed by adding 10 ml of fixative; the first 2 ml should 
be added dropwise while agitating gently. 
m)  The fixation procedure was repeated two more times. 
n)  The cell pellet was resuspended in appropriate volume of fixative solution after       
removal of the supernatant.   
o)  10 µl suspension was dropped onto a cleaned and cold microscope slide. 
p) After air-dry, slide was covered with two drops of antifade medium 
(VECTASHIELD mounting medium for fluorescence with DAPI, Cat: H-1200, 
Vector labs, U.K). A coverslip was added and sealed. 
q)  Karyotype analysis was performed under a fluorescent microscope (Axiovert 
200M; Zeiss, Hallbergmoos Germany) 
 
3.4.5.3 Characterization of MSCs 
 
3.4.5.3.1 Differentiation of MSCs into osteogenic lineage 
Cells were seeded at 5000 cells per cm2 in a 6-well plate, and maintained in culture 
medium (MesenCult Medium, DMEM or DMEM with 4ng/ml FGF (fibroblast 
growth factor) until they reached a confluence of 70-80% in a humidified 5% CO2 
incubator at 37°C. The cells were induced by osteogenic differentiation medium 
composed of high-glucose DMEM, 100 nM dexamethasone, 50 µM L-ascorbic acid, 
10 µM β-glycerophosphate, 10% FCS (HyClone), and 1% antibiotic-antimycotic 
(Biological Industries) for 3 or 5 weeks. Half of the medium was replaced every 3 
days. Calcium deposits were stained with the method of von Kossa. The 
differentiation assays were repeated 3 times for 3 weeks and one time for 5 weeks. 
 
3.4.5.3.2 Differentiation of MSCs into adipogenic lineage 
Cells were seeded at a density of 2 x105 cells/well in 6-well plate and cultured in 
culture medium until confluent. Then they were induced in high-glucose DMEM, 1 
µM dexamethasone, 10 µg/ml insulin, 500 µM 3-methyl-isobutylxantine, 200 µM 
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indomethacine, 10% FCS, and 5% rabbit serum for three days, alternately cutured one 
day in maintenance medium, composed of  high-glucose DMEM, 10 µg/ml insulin, 
10% FBS, and 5% rabbit serum. After three cycles, adipogenic differentiation was 
visualized after staining with 0.3% Oil red O for 5 minutes at room temperature and 
rinseing with 60% isopropanol. 
  
3.4.5.3.3 Differentiation of MSCs into chondrogenic lineage 
Cells were seeded at a density of 5 x 105 cells/tub in high-glucose DMEM medium 
supplemented with 50 µg/ml ascorbate-2-phosphate, 40 µg/ml proline, ITS, 100 nM 
dexamethasone, 1% FCS, 10 ng/ml TGF-beta3, and 200 ng/ml BMP-2 . Medium was 
changed three times a week very carefully by aspirating using pipette. 
Glycosaminoglycans (GAG) were quantificated using chondroitin sulphate as 
standard curve, and DNA was quantificated by Quant-iT Pico Green dsDNA Assay 
Kit (Invitrogen,  Cat. No. P7589).  
 
3.4.6 Immunofluorescence staining of donor cells for detection of histone 
methylation modifications 
An antibody that recognizes specifically di- and tri-methylated lysine 4 on histone H3 
(H3K4m2/3) was used as an epigenetic marker for transcriptionally competent 
chromatin, i.e. euchromatin; and another antibody, binding specifically to tri-
methylated lysine 27 on histone H3 (H3K27m3), was applied as a marker for 
transcriptionally silent chromatin, i.e. heterochromatin.  
 
3.4.6.1 Immunofluorescence 
a)   MSCs and RAFs were grown and attached on glass coverslips until eighty percent 
confluent.  
b) Specimens were briefly washed in PBS at 37°C and fixed in 3.7% 
formaldehyde/PBS for 10min at room temperature.  
c) After three times washing in 0.02% Tween 20/PBS (PBST) specimens were 
permeabilized by incubation in 0.5% Triton X-100 in PBS for 30 min at room 
temperature.  
d)   Finally specimens were washed three times in PBST. 
   
                                                                                                       Material and mathods 
32 
 
e)   For an initial blocking, specimens were put in 4% BSA/PBST for 30 min at room       
temperature. 
f)  Specimens were incubated with primary antibodies diluted appropriately in 4%    
BSA/PBST for two hours at room temperature. The following primary antibodies        
were used separately: polyclonal rabbit anti-histone H3 tri-methylated at lysine 27      
(Upstate 07-449; diluted1/100) and monoclonal mouse anti-histone H3 di-/tri-       
methylated at lysine 4 (Abcam ab6000; diluted 1/400).  
g) After four times washing in PBST, the following secondary antibody dilutions in 
4% BSA/PBST were applied for one hour at room temperature: goat anti-mouse 
IgG (H+L) Alexa 488 (Molecular Probes A-11029; diluted 1/400) and goat (Fab 
fragment) anti-rabbit IgG (H+L) Cy3 (Jackson ImmunoResearch 111-167-003; 
diluted 1/200).  
h)  Cells were washed 5 times in PBST, counterstained with the DNA dye TO-PRO-3      
(Molecular Probes; 2 µM) for 5 minutes at room temperature and mounted on a 
glass slide using Vectashield (Vector Laboratories) antifade medium.  
 
3.4.6.2 Confocal microscopy 
Cells were imaged on a Leica TCS SP1 confocal laser scanning microscope using a 
63x/1.32NA oil immersion objective lens. Fluorochromes were excited by a 488 nm 
Argon laser, 561 nm and 633 nm Helium-Neon lasers. An optimal detection range 
was adjusted by appropriate emission AOTF settings. To quantify fluorescence 
intensities mid-confocal sections of cell nuclei were collected using identical imaging 
parameter. Cultured cells from the various nuclear donor cell types used as a reference 
were fixed at a comparable passage number (±1).  
 
3.4.6.3 Image analysis 
Image analysis was done utilizing ImageJ 1.37v (http://rsb.info.nih.gov/ij/). To 
calculate mean fluorescence intensities within the limits of the nuclear area, all 
micrographs were synchronized to the image with the DNA counterstain where the 
nuclear border could be manually outlined. These margins were then applied to the 
micrographs of the antibody staining. The mean fluorescence intensity was 
normalized to the mean fluorescence intensity value averaged from 11 cellular nuclei 
of the respective donor cell type stained and imaged on the same day. This resulted in 
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a relative fluorescence intensity value representing the ratio of the signal intensity of 
an embryo nucleus to the signal intensity in the donor cell type. Statistics were 
analyzed by ANOVA using the MIXED procedure of SAS.  
 
3.5 Nuclear transfer, fusion and activation 
Nuclear transfer was done essentially as described by Yang et al. (2007). Briefly, 
individal RAFs or MSCs were inserted by micromanipulation under the zona 
pellucidae of the enucleated oocytes in M199. To induce membrane fusion, the 
reconstructed embryos were submitted to electro-stimulation (3DC pulses of 1.95 
KV/cm, 25 µs×2, 1sec interval) and the fusion was checked in 20 min later. After 
fusion, the cloned embryos were immediately incubated for 30 min in B2 medium 
(Laboratories CCD, Paris France) containing 1.9 mM 6-DMAP, 5.0 µg/ml CB and 
10% FCS in a humidified atmosphere of 5% CO2 in air at 38.5°C. Finally, embryos 
were applied one more time electro pulse and incubated in activation medium another 
30min.  
 
3.6 Embryo culture and transfer  
After activation, cloned embryos were cultured overnight in 100µl microdrop of B2 
medium containing 10% FCS at 38.5°C under 5% CO2 in air. Four-cell stage 
reconstructed embryos (about 15) were transplanted non-surgically through the 
infundibulum into each oviduct of recipients which had been induced into 
pseudopregnancy state at 20-22 h later in comparison to the oocyte donors. Pregnancy 
was checked by palpation around 14 days after embryo transfer. Blastocyst 
development rates were assessed after in vitro culture for up to 5 days. 
 
3.7 Immunofluorescence staining of embryos  
3.7.1 Embryo fixation 
a)  Embryos were washed 2 or 3 times in PBS to remove the culture medium. 
b) 10-15 embryos were treated with acidic Tyrode’s solution for 1-2 min, while 
pipetting them constantly in order to prevent them from sticking to the bottom. 
The process was controlled using a binocular microscope.  
c) After zona removal, embryos were transferred into the fixation solution (3.7% 
paraformaldehyde/PBS) directly for 15 min at room temperature. 
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f)  Embryos were washed three times in mPBS and one  time in PBST, then stored in 
PBST at 4°C for no longer than 1 week before application of antibodies. 
 
3.7.2 Immunofluorescence 
a)  Embryos were permeabilized by incubation in 0.5% Triton X-100 in PBS for 
30min at room temperature. 
b)  For an initial blocking, specimens were put in 4% BSA/PBST for 30 min at room     
temperature. 
c)  Specimens were incubated with primary antibodies diluted appropriately in 4%      
BSA/PBST for two hours at room temperature. Following primary antibodies 
were used simultaneously: polyclonal rabbit anti-histone H3 tri-methylated at 
lysine 27 (Upstate 07-449; diluted1/100) and monoclonal mouse anti-histone H3 
di-/tri-methylated at lysine 4 (Abcam ab6000; diluted 1/400). 
d)  After four times washing in PBST, following secondary antibody dilutions in 4% 
BSA/PBST  were applied for one hour at room temperature: goat anti-mouse IgG 
(H+L) Alexa 488 (Molecular Probes A-11029; diluted 1/400) and goat (Fab 
fragment) anti-rabbit IgG (H+L) Cy3 (Jackson ImmunoResearch 111-167-003; 
diluted 1/200). 
e)   Embryos were washed and equilibrated in 20, 40 and 60% glycerol/PBST for 15 
min each at room temperature before transferring them to poly-lysinated Lab-Tek 
8-well chambers with a coverglass bottom (Nunc). Equilibration was performed to 
prevent morphological damaging of embryos due to the change of solution density 
from PBST to the glycerol based antifade medium. 8-well chambers were poly-
lysinated by covering the glass surface with a Poly-L-lysine solution (5mg/ml) for 
1h before removing it. Excess solution was removed from the transferred embryos 
and they were left in a small drop of 60% glycerol over night at 4°C to adhere 
them to the glass surface. The next day embryos were covered with Vectashield 
antifade medium supplemented with TO-PRO-3 (50 µM). 
   
3.7.3 Confocal microscopy 
It was done as the same as 3.1.4.6.2. In order to compare fluorescence intensities of 
embryos stained on different days, signal intensities of embryonic nuclei were 
normalized to fluorescence intensities of cell nuclei stained on the same day. This was 
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done to correct for eventual differences in the efficiency of antibody staining in 
individual experiments done on different days.  
 
3.7.4 Image analysis 
It was done as 3.1.4.6.3. In vivo fertilized embryos were normalized to RAF 95 
nuclei. Between 7 and 19 embryos equivalent to 9-38 nuclei per stage were analyzed. 
Relative fluorescence intensity values of an individual stage were statistically 
compared to the respective previous stage as well as to the same stage of in vivo 
fertilized embryos by an ANOVA approach.   
 
3.8    Culture of in vivo fertilized and cloned rabbit embryos 
Cloned embryos were produced as above and in vivo fertilized zygotes were collected 
16-18 h after mating. 15-20 embryos were cultured in 100-µl microdrop B2 medium 
with 10% FCS and checked under microscope in every 2 hours. 
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4 RESULTS 
Cloned rabbits have been produced from cumulus cells and cultured fibroblast cells in 
our previous work (Yang et al. 2007), but the cloning efficiency was very low (0.2- 
0.6%) and not considerably improved (1.8%) following aggregation of cloned 
embryos with blastomeres of in vivo fertilized or parthenogenetic embryos. In this 
study, MSCs were used for NT to test whether these cells which possess high degree 
of developmental plasticity would be better nuclear donors compared to other somatic 
cells.  
 
4.1 Isolation and characterization of MSCs 
4.1.1  Isolation of cell lines 
In total, ten MSC lines were established from bone marrow using the same protocol 
and conditions. Most of non-adherent cells were removed during first medium change 
around 24 h. Discrete colonies of fibroblast-like cells attached to the plastic at 2-3 
days after initial seeding. Most cell lines were composed of cells with a characteristic 
spindle shape, whereas others had cells with polygonal morphology. Cells reached 80-
90% confluence on day 7-10 after seeding (Fig. 4).  
 
 
Fig. 4 Mesenchymal stem cells 
 
4.1.2 Life span of cultured MSCs and RAFs 
Freshly isolated MSC and RAF cells (passage 0) from 4 to 6-week-old rabbits were 
cultured independently until confluence, and were then passaged continuously until 
they reached replicative senescence. Passage one MSCs and RAFs were cultured either 
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in MesenCult Medium or in DMEM/F12 and the growth curves were recorded to 
determine their life span. In MesenCult Medium, MSC 93 and 95 were passaged 23 
and 24 times until they reached 60 and 66 population doublings (PDs), respectively, 
whereas RAF 93 and 95 reached only 30 and 31 PDs, respectively, after 15 passages 
(Fig. 5). In DMEM/F12 medium, cells of both types, exhibited reduced proliferation 
capacity, however, MSC 93 and 95 reached more PDs (31 and 32, respectively) than 
RAF 93 and 95 (23 and 24, respectively), when they finally ceased to divide at passage 
10-12 (Fig. 6). As passage and PD numbers increased, both MSCs and RAFs showed 
morphological changes, including flattened morphology and enlarged cell size.  
 
Table 3 Proliferation capacities of MSCs and RAFs 
Cell 
type 
Culture medium Total 
passages 
Days of culture Total PDs 
MesenCult MSC 
medium 
24 90 66 MSC 95 
DMEM/F-12 medium 12 63 32 
MesenCult MSC 
medium 
14 60 31 RAF 95 
DMEM/F-12 medium 11 51 24 
MesenCult MSC 
medium 
23 81 60 MSC 93 
DMEM/F-12 medium 12 59 30 
MesenCult MSC 
medium 
14 54 30 RAF 93 
DMEM/F-12 medium 11 44 23 
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Fig. 5 Growth curves of rabbit MSCs and RAFs cultured in MesenCult MSC 
medium 
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Fig. 6 Growth curves of rabbit MSCs and RAFs cultured in DMEM/F-12 
medium 
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4.1.3 Karyotype analysis 
In total about 60 metaphase spreads of RAFs and MSCs in 3 replicates were analysed 
at passage 12. All these spreads had normal chromosome number of 44 (Fig. 7). 
 
 
Fig. 7 Metaphase spread of a rabbit mesencymal stem cell 
  
4.1.4 Differentation of MSCs into Osteogenic lineage 
Cells cultured under osteogenic induction medium produced calcium deposits 
detected by von Kossa stain (Fig. 8). 
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Fig. 8 Osteogenic differentiation of rabbit MSCs 
A,C,E,G: stimulated MSCs; B,D,F,H: unstimulated controls MSCs; calcium deposits 
stained in black (von Kossa); 
(A)+(B) human MSC; (C)+(D) rabbit MSCs expanded in MesebCult Medium; 
(E)+(F) rabbit MSCs expanded in DMEM; (G)+(H) rabbit MSCs expanded in DMEM 
with FGF   
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4.1.5 Differentation of MSCs into adipogenic lineage 
Differentiation of MSCs into adipogenic lineage was identified by oil red staining of 
lipid vacuoles. In the adipogenic differentiated cells, red stained vacuoles were 
deteced (Fig. 9). 
 
 
Fig. 9 Adipogenic differentiation of rabbit MSCs 
A,C,E: stimulated MSCs; B,D,F: unstimulated controls MSCs; lipid deposits stained 
in red. 
 
4.1.6 Differentiation of MSCs into chondrogenic lineage 
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The glycosaminoglycans were quantified according to the chondroitin sulphate 
standard. Cell line MSC93 reached to 155.5 ng chondroitin/µg DNA, whereas other 
two cell lines didn’t get that high concentration, 8.4 ng and 10.2 ng, respectively (Fig. 
10). 
 
Fig. 10 Chondrogenic differentiation of rabbit MSCs 
 
4.2 Development of embryos cloned from MSCs 
In the first series of experiments, we established and tested as donors for NT two 
MSC lines. Rates of development to blastocysts varied from 50 to 76% and tended to 
be higher with the cells at early passages (Table 4). Transfer of 404 cloned 4 to 8-cell 
stage embryos into 10 recipients resulted in 5 pregnancies and the birth of one rabbit 
which lived only for a few hours. Neither transfer of cloned embryos at one-cell stage 
nor co-transfer with parthenogenic embryos improved pregnancy or offspring rates.  
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Table 4 Development of embryos cloned from MSC lines 
Donor cell 
/passage 
Fused 
(%) 
Cleaved 
(%) 
Blast 
(%) 
Embryos/ 
Recipients 
Pregnant 
recipients 
Rabbits 
born 
R3 
p1-5 
177/177 
(100)a 
135/151 
(89)a 
38/76 
(50)a,b 
68+8/2*** 1* 0 
R3 
 p8-12 
340/340 
(100)a 
263/278 
(94)b 
26/48 
(58)a,b 
132/2 
75+13/2*** 
0 
0 
0 
0 
R8 
p3-7 
206/207 
(99)a 
172/202 
(85)a 
26/38 
(68)a 
132/4 2(1*) 1 
R8 
p14-17 
367/381 
(96)a 
190/235 
(80)a 
23/58 
(40)b 
140/4 
106/2** 
3* 
0 
0 
0 
Total 1081/1087 
(99) 
747/848 
(88) 
102/20
2 
(50) 
404/10 
106/2** 
143+21/4**
* 
5(4*) 
0 
1* 
1 
0 
0 
*Recipients were slaughtered on day 13-17; **one-cell embryos were transferred;  
***Co-transfer with parthenogenetic embryos; a,b: values within the same column 
with different superscripts were significantly different (P<0.05). 
 
4.3 Development of embryos cloned from the cells of MSC A/B line 
In the second series of experiments we used another MSC A/B line, either at early 
passage or after storage of donor cells in liquid nitrogen. Cleavage and blastocysts 
rates obtained with cells before their storage were significantly higher than that those 
obtained with cells used after one year storage in liquid nitrogen (Table 5). Transfer 
of 357 cloned embryos into 10 recipients resulted in four pregnancies and one cloned 
rabbit (Fig. 11) which lived for three days. When other three recipients were 
slauthered on day 13 after embryo transfer, nine implantations were found and 7 of 
those were in one recipient (Fig. 12).  
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Table 5 Development of embryos cloned from the cells of MSC A/B line 
Donor 
cell/passage 
Fused 
(%) 
Cleaved 
(%) 
Blastocysts 
(%) 
Embryos/ 
Recipients 
Pregnant 
recipients 
Rabbit 
born 
BMC A/B, 
1-4 
181/181 
(100) 
154/159 
(97)a 
77/102 
(76)a 
- - - 
BMC A/B, 
5-8* 
261/269 
(97) 
212/246 
(86) b 
78/175 
(45)b 
37/1 1 1 
BMC A/B, 
9-13* 
596/621 
(96) 
378/603 
(63)b,c 
23/68 
(34) b,c 
320/9 3 0 
* Cells were used after one year storage in liquid nitrogen; 
a,b,c: Values within the same column with different superscripts were significantly 
different (P<0.05). 
 
 
Fig. 11 One-day old live rabbit cloned from a MSC  
 
 
Fig. 12 Resorbed conceptuses on day 13 after embryo transfer 
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4.4 Development of embryos cloned from genetically matched MSCs and RAFs 
To exclude possible effects of different genetic background of donor cells on the 
efficiency of NT, two MSC and two RAF lines from the same rabbits were 
established and tested as nuclear donors. The proportions of embryos that cleaved 
were not different between the MSC and RAF groups (Table 6). However, within the 
isogenic groups, significantly more embryos (P<0.05) cloned from RAF 93 cells 
developed to blastocyst than those derived from MSC 93 cells, whereas there was no 
significant difference in the proportions of cloned blastocysts derived from MSC 95 
and RAF 95 cells.  
 
Table 6 Development of embryos cloned from genetically matched MSCs and 
RAFs 
Donor cells Fused (%) Cleaved (%) Blastocysts (%) 
BMC 93 204/207 (99) 188/203(93)a 53/182(29)a 
RAF 93 172/175 (98) 151/171 (88)a 78/169 (46)b 
BMC 95 209/223 (94) 164/200 (82)b 88/200 (44)a,b 
RAF 95 173/189 (92) 132/161 (82)b 80/161 (50)b 
a,b: Values within the same column with different superscripts were significantly 
different (P<0.05). 
 
4.5 Immunofluorescence staining to detect histone methylation modifications 
 
4.5.1 Histone methylation status of donor cells prior to nuclear transfer  
Analysis of H3K27m3 modification revealed the expected staining pattern in nuclear 
donor cells, typically high lighting the inactive X-chromosome in female cell lines 
(MSC 93 and 95, and RAF 93 and 95) (Fig 13, 14, 15). For H3K4m2/3 modification, 
strong staining with small foci was detected in all donor cells. In female cells the 
inactive X chromosome (identified as Barr body via DNA staining) showed reduced 
levels of H3K4m2/3 (Fig. 13-15).  
 
4.5.2 Histone methylation status of in vivo fertilized and cloned embryos  
H3K27m3 modification was not detected in the zygote to morula stages of in vivo 
embryos (Fig. 13). Only in blastocysts a weak staining of a single domain in some 
                           
                                                                                                                               Results 
46 
 
embryos in a few cells was visible, probably resembling the inactive X of female 
embryos. Since during simultaneous analysis of both modifications H3K4m2/3 
signals were strong a staining, artifact can be excluded. 
Irrespective of the type of donor cells, in all stages of NT embryos except for one-cell 
embryos and blastocysts, H3K27m3 was undetectable (again, as an internal control, 
signals for H3K4m2/3 were always observed) (Fig. 14,15). In the majority but not all 
one-cell embryos derived from MSC 95, RAF 93 and RAF 95 a very weak staining 
was observed, while essentially no signals were detected at the same stages of 
embryos cloned from MSC 93 and MSC A/B. In blastocysts derived from RAF 95 
and MSC 95 a weak staining of one domain similar to in vivo embryos was seen in 
few cells of some embryos. No signals for H3K27m3 were detected in blastocysts 
derived from the other cell types. Generally, it seems that H3K27m3 is successfully 
reprogrammed in transferred nuclei of all donor cell types, with minor differences in 
embryos at the one-cell and blastocyst stages. 
High levels of in H3K4m2/3 (euchromatin) observed in in vivo embryos at the one- 
and 2-cell stages decreased slightly at the 4-cell stage, followed by a more drastic 
drop at the 8-cell stage, where there was a minimum of measured fluorescence 
coinciding with the time point of major genome activation. At the 16-cell stage 
signals were slightly increased, while in morulae and blastocysts those reached similar 
levels as at the one- and 2-cell stages.  
Fluorescence signals for H3K4m2/3 detected in NT embryos derived either type of 
donor cells differed from those of in vivo embryos (Fig. 14, 15, 16). A minimum was 
not reached at the 8-cell stage, but at the 4-cell stage, where in in vivo embryos the 
signals were still strong. Reprogramming of H3K4m2/3 modification occurred quite 
differently with either type of cells irrespective of the cell origin or type. However, all 
types of donor nuclei were reprogrammed to some degree, as the fluorescence 
increased already in one-cell stage and remained high or increased again at the 2-cell 
stage, except for RAF 95. It is worth noting that NT embryos derived from MSC A/B 
differed from all others in the way that fluorescence levels were generally lower and 
remained in the range of the donor cells, as if they would be more refractory to an 
elevation of global H3K4m2/3 levels. Similar to embryos generated from MSC A/B, 
those cloned from RAF 95 showed reduced H3K4m2/3 levels at the morula and 
blastocyst stages. Another noticeable aspect is that at the 8-cell stage, when in vivo 
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embryos reached their minimum, the H3K4m2/3 levels were still quite low for all 
MSC cell lines (MSC 93, 95 and A/B), while they were already elevated in embryos 
cloned from fibroblasts (RAF 93 and 95) (Fig. 14, 15, 16). 
 
 
 
Fig. 13 Patterns of H3K4m2/3 and H3K27m3 in rabbit in vivo fertilized embryos 
and fibroblast cells 95 (left column) 
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Fig. 14 Patterns of H3K4m2/3 and H3K27m3 in RAF 93 NT embryos and 
fibroblast cells 93 (left column) 
 
 
 
Fig. 15 Patterns of H3K4m2/3 and H3K27m3 in MSC 93 NT embryos and MSCs 
93 (left column) 
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Fig. 16 Patterns of H3K4m2/3 rabbit in vivo embryos and embryos cloned from 
MSC (93, 95 and A/B), RAF (93 and 95) 
 
4.6 Comparison of the time course of preimplantation development of in vivo 
fertilized and cloned rabbit embryos  
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We found that zygotes need about 24-26 h to cleave into 2-cell embryos, while cloned 
one-cell embryos undergo first cleavage division in 10-12 h after activation (Table 7). 
To reach futher stages of development cloned embryos need two hours more than in 
vivo fertilized embryos indicating some degree of developmental delay in the former.  
 
Table 7 Timing of preimplantation development of in vivo fertilized and cloned 
embryos 
Embryonic stage Normal fertilized embryos, 
time post mating/doubling 
time (hours) 
NT embryos, time post 
activating/doubling time 
(hours) 
Oocyte 12-14/- - 
Zygote 18-20/- - 
2-cell 24-26/6 10-12/10-12 
4-cell 30-32/6 18-20/8 
8-cell 38-40/8 26-28/8 
16-cell 46-48/8 36-38/10 
Morula 54-56/8 46-48/10 
Compact morula 64-66/10 58-60/12 
Early blastocyst 76-78/12 72-74/14 
Expanded blastocyst 84-86/8 82-84/10 
Hatched  blastocyst 94-96/8 92-94/10 
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5 DISCUSSION 
Reprogramming of epigenetic modifications established on the chromatin of donor 
cells plays a key role following NT and is largely dependent on the cell origin and 
type. Whether various donor cells differ in their ability to successfully pass through 
the process of epigenetic reprogramming was the question addressed by numerous 
studies on SCNT (Kato et al. 2000; Santos et al. 2003; Tamada and Kikyo 2004; 
Armstrong et al. 2006). In our previous study in rabbit, we found that embryos cloned 
from cumulus cells were more similar to in vivo fertilized embryos in respect to 
reprogramming of acH3K9/14 than those derived from fetal fibroblasts (Yang et al. 
2007). However, cloning efficiency estimated by blastocyst and offspring rates was 
not significantly different between these two groups. Here, we tested two types of 
donor cells, mesenchymal stem cells and adult fibroblasts, which are considered to be 
different in the state of differentiation. The main results of the present study include 
cloning for the first time rabbits from MSCs and demonstration of reprogramming 
dynamics of hetero- and euchromatic histone modifications. 
 
5.1 Effects of donor cell type on nuclear transfer efficiency 
 
5.1.1 Mesenchymal stem cells 
MSCs have already been used for SCNT in different species, but the results do not 
shed light on the question whether these cells are better nuclear donors than other 
somatic cells. In the first report on the use of bovine MSCs for SCNT it has been 
suggested that cloned embryos do not have a higher developmental potential, both in 
vitro and in vivo, than those produced from the cells of non-stem cell origin (Kato et 
al. 2004). However, their findings were based on a relatively small data set, which 
lacked a comparison of NT with other cell types as a control. Subsequent studies 
provided less certainty but rather contradictory results. While Colleoni et al. (2005) in 
cattle and pigs, and Bosch et al. (2006) in pigs reported similar blastocyst rates 
reconstructed with MSCs and adult fibroblasts, Faast et al. (2006) showed that the 
percentage of blastocysts cloned from porcine MSCs was almost two-fold higher than 
those derived from adult fibroblasts. The latter study compared two different cell 
types originating from the same animal that excludes likely effect of genetic 
background, however, when porcine MSCs were isolated from blood but not from 
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bone marrow they were not superior to fibroblasts in generating cloned blastocysts. 
The reasons for such apparent difference between MSCs isolated from bone marrow 
and blood are unknown but a likely explanation could be that these cells were 
obtained from different animals and the experiments performed at different times. 
Similar to the findings of Faast et al. (2006), other studies in pigs have also reported 
higher blastocyst rates with porcine bone marrow MSCs (Kumar et al. 2007) or 
porcine skin-derived fetal stem cells (Zhu et al. 2004) than with fetal fibroblasts. All 
these reports provide evidence that the efficiency of SCNT with MSCs can be 
different not only between laboratories but also within the same laboratory and 
species. The differences might also be the result of the respective nuclear transfer 
protocol used in either study.  
 
5.1.2 Effect of passage number of MSCs on in vitro development of NT embryos 
Production of transgenic cloned rabbits requires long term culture of donor cells for 
stable integration of a transgene and selection of transfected cells prior to NT. In this 
study, MSCs were cultured until passage 23 or 24 (about 60 PDs) in a specific culture 
medium, and this proliferation capacity was higher than that of bovine and porcine 
MSCs (50 and 40 PDs, respectively; Colleoni et al. 2005). The blastocyst rate of 40% 
obtained with passage 14-17 R8 MSCs was significally lower compared to that with 
these cells at passage 3-7, suggesting that later passage MSCs can be appropriate 
nuclear donos but short time cultured cells may be superior in supporting the 
developemt of cloned embryos.  
 
5.1.3 Effect of storage of MSCs on in vitro development of NT embryos 
A decline in developmental potential of MSC A/B after one-year storage in liquid 
nitrogen (76% vs. 45%, P<0.05) was observed, suggesting that environmental 
conditions may affect the stability, both genetic and epigenetic, of MSCs. Consistent 
with our observations, others groups have also shown that neither refrigeration of 
donor cells for 1-2 weeks nor their freezing with a controlled cooling rate for several 
weeks or months compromised development of NT embryos (Liu et al. 2001a; Hayes 
et al. 2005). However, it must be taken into account that cell cryopreservation as well 
as trypsinization can cause chromatin rearrangements and loss of nuclear and 
cytoplasmic proteins (Chu 1962; Maizel et al. 1975). Moreover, dimethyl sulfoxide 
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(DMSO), a cryoprotectant usually used for cell freezing, is a known methylating 
agent (Iwatani et al. 2006) that might affect the developmental capacity of frozen 
cells. 
 
5.1.4 Effect of donor cell line of MSCs on in vitro development of NT embryos 
As demonstrated in pigs and cattle (Kuhholzer et al. 2001; Poehland et al. 2007) not 
only different cell lines, but also clones derived from one primary cell line can differ 
in their developmental potential when used for NT, suggesting that a particular cell 
line, irrespective of its origin, has unique intrinsic characteristics, inherent or 
acquired, which may affect its potential for NT. The results of the present study are in 
good agreement with numerous studies that argue for an unpredictable outcome when 
using MSCs as nuclear donors. In fact, our study, which to our knowledge is the first 
to assess the developmental potential of rabbit MSCs as nuclear donors, yielded all 
possible scenarios including a similar, lower or higher developmental potential of 
MSCs compared to fibroblasts suggesting that either cell line of MSCs has unique 
intrinsic characteristics affecting its ability for reprogramming following NT.  
 
5.1.5 Fibroblast cells 
Unlike MSCs, two fibroblast cell lines tested in the present study showed similar 
developmental potential suggesting that fibroblast cells are more stable than cells of 
stem cell origin. Embryonic stem (ES) cells, the best studied type of stem cells, show 
a remarkable epigenetic and genetic instability and even sister cells of freshly 
subcloned ES cells can exhibit substantial variation in gene expression (Humpherys et 
al. 2002). Pre-existing epigenetic errors in combination with faulty reprogramming 
during NT may cause gene expression abnormalities in ES cell derived clones, which 
are specific to the particular donor nucleus and the differences appear to reflect the 
epigenetic state of the respective donor nucleus. Whether this is the case with adult 
stem cells remains to be clarified. Presently, the epigenetic state of adult stem cells is 
not well known and molecular events regarding epigenetic reprogramming of the 
chromatin of adult stem cells are poorly understood. It remains also debatable whether 
adult stem cells are better donors than differentiated cells for cloning by NT 
(Hochedlinger and Jaenisch 2007). When testing the hypothesis as to whether SCNT 
clones can be generated directly from truly differentiated somatic cells with mouse 
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hematopoietic stem cells at different differentiation stages, Sung et al. (2006) found 
that cloning efficiency increases over the differentiation hierarchy, and the greatest 
cloning efficiency was achieved using terminally differentiated postmitotic 
granulocytes. Unlike using hematopoietic stem cells, a high efficiency of blastocyst 
development and ES cell derivation was demonstrated when neural stem cells were 
used for SCNT (Blelloch et al. 2006) thus arguing that some lineages somatic stem 
cells might be more efficiently reprogrammed that their differentiated counterparts. 
Comparison of the expression pattern of genes implicated in transcription and 
pluripotency, DNA methylation and histone deaacetylation, growth factor signaling, 
imprinting and apoptosis revealed that porcine embryos cloned from MSCs were 
more similar to in vivo derived embryos than embryos cloned from fetal fibroblasts 
(Kumar et al. 2007) suggesting that MSCs with a relatively undifferentiated genome 
are more efficiently reprogrammed and might be better donors for NT. In general, it 
can be assumed that different types of adult stem cells differ in the degree of genomic 
plasticity and therefore might not be equal in terms of reprogrammability following 
NT. The question whether the genomes of adult stem cells are similar to ES cells in 
that they are easier to reprogram than the genomes of terminally differentiated cells 
might not be easily answered and might in fact be dependent on the specific lineage. 
 
5.2 Reprogramming of histone modifications in embryos cloned from MSCs and 
      RAFs  
It was believed that histone methylation is an extremely stable modification.  
However, recent discoveries of several classes of lysine demethylase, the 
LSD1/BHC110 class (which removes H3K4me1/2) (Lee et al. 2005b) and the jumonji 
class (which removes H3K4me2/3, H3K9me2/3, and H3K36me2/3) (Cloos et al. 
2006; Tsukada et al. 2006; Christensen et al. 2007; Park et al. 2007) have put to an 
end debates about the reversibility of histone lysine methylation. Demethylation and 
re-methylation of histone lysine residues following NT appear to be critical for the 
regulation of gene expression and for the establishment of totipotency of cloned 
(Oback and Wells 2002). Since the somatic gene expression program has to be turned 
off before embryonic gene expression is established, repressive histone methylation 
that occurs after NT would facilitate somatic gene silencing. In the present study, 
which to our knowledge is the first report addressing the epigenetic status of embryos 
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cloned from MSCs, we investigated the changes of H3K27m3 and H3K4m2/3 in 
SCNT embryos compared to in vivo embryos and found that these two histone 
modifications are reprogrammed to a certain degree but the dynamics of their 
reprogramming significantly differ.  
 
5.2.1 Reprogramming of H3K27m3 modifications in cloned embryos 
Like in in vivo embryos, with minor differences in zygotes and blastocysts, H3K27m3 
was undetectable at all stages of NT embryos except for one-cell embryos and 
blastocysts suggesting faithful reprogramming of this modification. In line with our 
findings in rabbit embryos, bovine embryos have shown a low level of the repressive 
marker H3K27m3 at the stage of major genome activation (MGA) (Ross et al. 2008). 
However, unlike in our study, they found H3K27m3 at all stages during 
preimplantation development, with the highest fluorescent intensity in immature 
oocytes, followed by a steady decrease after fertilization to a minimum at the 8-cell 
stage, at the time of MGA, with a subsequent increase until the blastocyst stage. In 
zygotes they could recapitulate an observation that had already been described for 
mouse embryos (Santos et al. 2005; van der Heijden et al. 2005), that only the 
maternal pronuclear chromatin is decorated with H3K27m3, while the male chromatin 
is essentially devoid of it. In contrast to their findings, we could not detect H3K27m3 
in any of the pronuclei in rabbit in vivo zygotes, although the modification was clearly 
present in MII oocytes.  
The reason for this discrepancy remains elusive, however species specific differences 
of early epigenetic reprogramming events might account for it. In fact such 
differences might represent a more general phenomenon, given that the dynamic of 
other epigenetic marks such as DNA methylation has been shown to vary 
considerably between species (Beaujean et al. 2004). In accordance to the presented 
data of in vivo rabbit embryos, we and others have observed a generally low level 
various repressive histone marks at the stage of MGA in bovine (Santos et al. 2003) 
and mouse (Liu et al. 2004; Huang et al. 2007; Ooga et al. 2008) embryos, suggesting 
that removal of such repressive epigenetic modifications may be an essential part of 
embryonic genome activation. 
Moreover, our finding of a low/undetectable level of H3K27m3 until the blastocyst 
stage parallels a continuous decrease of 5-methyl cytosine, a DNA modification that 
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is usually associated with transcriptional silencing and which in several mammalian 
species including rabbits has been shown to be actively (paternal genome) or 
passively (maternal genome) removed during preimplantation development (Mayer et 
al. 2000; Oswald et al. 2000; Dean et al. 2001a). 
 
5.2.2 Reprogramming of H3K4m2/3 modifications in cloned embryos 
H3K4m2/3 was found in all stages of in vivo as well as NT embryos, but the 
fluorescence intensity ratios in embryos cloned from either MSCs or RAFs were not 
similar to that of in vivo embryos suggesting an aberrant reprogramming of this 
chromatin modification. Our results corroborate previous observations that epigenetic 
reprogramming occurs abnormally in a large proportion of cloned embryos (Dean et 
al. 2001b; Kang et al. 2003; Santos et al. 2003; Hiendleder et al. 2004; Wee et al. 
2006). Unlike with other specific histone modifications, which have been proposed as 
epigenetic markers to assess the process of nuclear reprogramming and predict SCNT 
efficiency (Santos et al. 2003; Yang et al. 2007) in the present study reprogramming 
of H3K4m2/3 modifications did not show clear correlation with the developmental 
potential of embryos cloned from any of the various utilized cell types. Moreover, 
embryos cloned from either cell type, irrespective of its origin, exhibited no close 
similarities in the reprogramming of H3K4m2/3 modification. NT embryos derived 
from MSC A/B differed from all others in the way that the fluorescence ratios were 
generally lower and remained in the range of the donor cells. It can be assumed that 
reprogramming of H3K4m2/3 is more aberrant with MSC A/B cells than with any 
other cell type used in this study. However, embryos cloned from MSC A/B cells 
developed to blastocysts with similar or higher rates than embryos derived from other 
cell types indicating little or no effect of H3K4m2/3 reprogramming on the 
subsequent development of reconstructed embryos.  The rather stochastic than regular 
reprogramming of this chromatin modification in NT embryos might be also due to 
differential remodelling (histone methylation and demethylation) activities present in 
the recipient cytoplasm. This is supported by the fact that fluorescence levels of 
H3K4m2/3 fluctuated stochastically between embryos at different stages.  
Patterns of epigenetic reprogramming of specific histone modifications appear to 
depend on the type of modification and species. In one study in mouse, histone 
H3K9m2/3 of somatic cells was gradually demethylated in the SCNT embryos 
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following activation (Wang et al. 2007). However, reprogramming patterns 
considerably differed for other epigenetic marks, as histones H3K9, H3K14, and 
H4K16 were quickly deacetylated following NT and then reacetylated following 
activation. In contrast, acetylation of histones H4K8 and H4K12 persisted in the 
genome of cloned embryos with only mild deacetylation during NT and activation. 
Histone H3K9 di- and trimethylation is correlated to gene silencing while histone 
H3K4 di- and trimethylation is involved in transcriptional competence and 
transcriptional activity, respectively (Santos-Rosa et al. 2002; Papp and Muller 2006). 
When analyzing the dynamics of H3K4m2/3 in rabbit NT embryos reconstructed 
from cells of different type and origin, we could observe a general reprogramming of 
the donor chromatin towards a situation similar to that found in in vivo embryos. 
Similar to the situation in in vivo embryos, H3K27m3 was readily erased from the 
one-cell stage on and remained below detectable levels. Accordingly, H3K4m2/3 
levels were initially elevated, in the one- or 2-cell stage and then declined rapidly to 
reach a minimum at the 4-cell stage, which is however anticipated compared to the in 
vivo situation where the minimum was reached at the 8-cell stage. The subsequent 
increase in in vivo embryos was also recapitulated in embryos reconstructed from all 
donor cells, although the extent varied considerably and in case of RAF 95 and RAF 
93 this increase was followed by a final decline in morulae and blastocysts. This 
general recapitulation of H3K4m2/3 levels in NT embryos trying to mimic the 
situation in vivo argues for an important functional significance of correct H3K4m2/3 
levels. The deviations observed in NT embryos might in the end be part of an aberrant 
reprogramming that leads to a high degree of developmental defects generally found 
in embryos reconstructed by nuclear transfer.   
Similar to our results showing a continuously high level of the euchromatic mark 
H3K4m2/3 in rabbit embryos, Huang et al. (2007) have shown a constantly high level 
of histone H4 acetylation in the mouse preimplantation development, a modification 
that is associated with genetically active chromatin. The direct impact of H3K4 
methylation on transcriptional activity during embryonic development was recently 
shown by Shao et al. (2008), who could demonstrate that hypermethylation of H3K4 
induced by a specific histone de-methylation inhibitor, can lead to a precocious 
activation of genes in early mouse embryos (Shao et al. 2008). On the other hand we 
were surprised to find a minimum of the euchromatic marker H3K4m2/3 at the 8 cell 
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stage, a stage where MGA is expected to take place, i.e. the chromatin should adapt a 
most open chromatin conformation and transcription-prone constitution. Interestingly, 
we had already observed such a drop in the level of a marker for trancriptionally 
competent euchromatin, namely histone H3K9/K14 acetylation, in both rabbit (Yang 
et al. 2007) and bovine (Santos et al. 2003) embryos at the time point of MGA.  
The reasons for this apparent contradiction are still unclear, but a possible explanation 
for this reduction in global euchromatic modifications could be that extensive histone 
modifications could hinder this first burst of embryonic transcription of the embryonic 
genome. In fact, the recruitment and binding of essential transcriptional constituents 
such as the basal transcription machinery or additional auxiliary transcription factors 
might be counteracted by too extensive histone modifications. Another possible 
explanation is that the presence of the transcription machinery and/or huge amounts of 
nascent RNA might mask antigens on the histone tails that would become less 
accessible for the antibodies used to visualize them. In fact in one of our previous 
studies on histone modifications dynamics during preimplantation development we 
have witnessed a low level of both, repressive and active marks at the time point of 
MGA (Santos et al. 2003). A somewhat similar, contracting finding recently presented 
by Ooga et al. (2008) who have shown that in the mouse embryo H3K79m2, a histone 
modification associated with active genes is rapidly lost from the maternal oocyte 
chromatin after fertilization and remains low at the 2 cell stage, i.e. during MGA. 
In conclusion, our study demonstrates that while H3K27m3 was faithfully 
reprogrammed following NT with all cell lines examined, patterns of H3K4m2/3 
differed between either group of cloned embryos irrespective of the origin or type of 
donor cells and did not resemble that of in vivo fertilized embryos, suggesting that 
reprogramming of this modification involves a more complex mechanism. 
Reprogramming of H3K4m2/3 did not correlate with developmental potential of 
embryos cloned from either type of donor cells. The criteria of cloning efficiency used 
in our study, i.e. development of cloned embryos to blastocysts and reprogramming of 
H3K27m3 and H3K4m2/3 modifications, could not provide convincing evidence for a 
correlation between the differentiation status of a donor nucleus and its epigenetic 
reprogramming. 
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6 SUMMARY 
The main aim of this thesis was to find out which donor cells would be most suitable 
for production of cloned rabbits with a targeted modification of their genome. Such 
donor cells must follow a number of criteria including high developmental potential 
for NT, high proliferation capacity and genetic stability during their manipulation and 
culture. To follow these criteria we have chosen mesenchymal stem cells (MSCs) 
isolated from a bone marrow, the cell type which is considered to be less 
differentiated than any somatic cells of non-stem cell origin. We have established 
several MSC lines and assessed their developmental potential and epigenetic 
reprogramming of the specific histone modifications compared to genetically matched 
rabbit adult fibroblasts (RAFs) isolated from the same rabbits. As a “golden standard” 
for epigenetic reprogramming of histone modifications we used in vivo fertilized 
embryos. Histone modifications were used as epigenetic markers which appear to be 
reasonable for evaluating the efficiency of nuclear reprogramming.  
As epigenetic markers for transcriptionally competent, as well as for silent chromatin, 
we have chosen antibodies that recognize specifically di- and tri-methylated lysine 4 
on histone H3 (H3K4m2/3) and tri-methylated lysine 27 on histone H3 (H3K27m3), 
respectively. Using three MSC lines, MSC 93, 95 and MSC A/B, and two RAF lines, 
RAF93 and 95, which are genetically matched to MSC 93 and 95, we analysed 
reprogramming of these epigenetically and functionally different chromatin 
modifications following nuclear transfer into enucleated oocytes. We also assessed 
whether histone methylation patterns of cloned embryos correlate with their 
developmental potential. Additionally we transferred some embryos cloned from 
MSCs into recipients to test their potential to develop to offspring. 
MSC 93 and 95 tended to differ in the ability to support the development of cloned 
embryos to blastocyst (29% and 44%, respectively) whereas similar (46% and 50%) 
blastocyst rates were obtained with RAF cell lines. Embryos cloned from fresh or 
long-term stored MSC A/B developed to blastocysts with significantly higher or 
similar rates (76% and 45%) compared to other cell lines. Transfer of 404 embryos 
cloned from cell lines MSC R3 and R8 into 10 recipients resulted in 5 pregnancies 
and the birth of one rabbit which lived only for a few hours. Neither transfer of cloned 
embryos at the one-cell stage nor co-transfer with parthenogenic embryos improved 
pregnancy or offspring rates. Transfer of 357 embryos cloned from cell line MSC A/B 
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into 10 recipients resulted in four pregnancies and one cloned rabbit which lived for 
three days. When other three recipients were slauthered on day 13 after embryo 
transfer, nine implantations were found.  
H3K27m3 was not detectable from the zygote to morula stages in in vivo embryos. 
Only in blastocysts a weak staining of a single domain in some embryos in a few cells 
was visible presumably resembling the inactive X chromosome. In all stages of 
nuclear transfer embryos except for one cell stage and blastocysts H3K27m3 was 
undetectable. It seems that H3K27m3 is faithfully reprogrammed in transferred nuclei 
of all donor cell types, with minor differences in zygotes and blastocysts. Strong 
signals for H3K4m2/3 were detected at the one to two-cell stages of in vivo embryos 
with a slight decrease at the 4-cell stage, followed by a more drastic decrease at the 8-
cell stage, where the signal minimum was reached. In 16-cell embryos signals slightly 
increased and then reached in morulae and blastocysts the levels observed in one-two 
cell embryos. In all types of nuclear transfer embryos fluorescence intensity ratios 
differed from that of in vivo embryos. The minimum was not reached at the 8-cell 
stage but at the 4-cell stage. Reprogramming of H3K4m2/3 modification occurred 
quite differently with either type of cells irrespective of the cell origin or type and no 
close similarities in the patterns of this reprogramming was observed between in vivo 
and nuclear transfer embryos. Embryos cloned from MSC A/B differed from all 
others in the way that H3K4m2/3 was generally lower and remained in the range of 
the donor cells. This suggests that reprogramming of H3K4m2/3 modification is more 
aberrant with MSC A/B cells than with any other cell type used in this study. 
However, with MSC A/B cells, a significantly higher or similar proportion of cloned 
embryos developed to blastocysts indicating that reprogramming of H3K4m2/3 
modification does not correlate with developmental potential of donor cells. 
In conclusion, our study provides evidence that histone modifications for 
heterochromatin are faithfully reprogrammed during NT of rabbit somatic cells, while 
patterns of epigenetic reprogramming of euchromatic histone modifications differ 
between individual cell lines irrespective of their origin or type and are not correlated 
with their developmental potential. Although MSCs were not superior to RAFs in 
respect to the criteria tested in our study they may be suitable nuclear donors for 
generating transgenic cloned rabbits due to their high developmental plasticity.  
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7 ZUSAMMENFASSUNG 
Reprogrammierung von mesenchymalen Stammzellen und reifen Fibroblasten 
durch Kerntransfer im Kaninchen 
 
Ziel dieser Arbeit war die Identifizierung von Kernspenderzellen, die für die 
Erzeugung klonierter Kaninchen mit einer gezielten genetischen Modifikation am 
geeignetsten sind. Kriterien für solche Kernspenderzellen umfassen ein hohes 
Entwicklungspotential nach dem Kerntransfer, eine hohe Proliferationskapazität 
sowie genetische Stabilität während der Manipulation und Kultur. Auf der Basis 
dieser Kriterien wurden mesenchymale Stammzellen (MSCs) aus dem Knochenmark 
isoliert, die als weniger differnziert gelten als alle somatischen Zellen ohne 
Stammzelleigenschaften. Im Rahmen dieser Arbeit wurden mehrere MSC Linien 
etabliert und hinsichtlich ihrer Entwicklungskapazität und epigenetischen 
Reprogrammierung hinsichtlich spezifischer Histonmodifikationen nach dem 
Kerntransfer untersucht. Als Vergleich dienten Fibroblasten (RAFs), die von den 
gleichen Spendertieren isoliert wurden. Als Goldstandard für die epigenetische 
Reprogrammierung der Histonmodifikationen während der frühen 
Embryonalentwicklung wurden Embryonen aus in vivo fertilisierten Eizellen 
untersucht. Histonmodifikationen wurden untersucht, da sie als epigenetische Marker 
für die Evaluierung der Effizienz der Kern-Reprogrammierung angesehen werden.  
Zur Detektion epigenetischer Marker für transkriptionsaktives bzw. –inaktives 
Chromatin wurden Antikörper gewählt, die spezifische di- und tri-methylierte 
Varianten des Lysin 4 im Histonprotein H3 (H3K4m2/3) bzw. tri-methyliertes Lysin 
27 im Histonprotein H3 (H3K27m3) erkennen. Für drei MSC Linien, MSC 93, 95 
und MSC A/B, sowie zwei RAF Linien, RAF93 und 95, die isogenetisch zu den MSC 
Linien 93 und 95 sind, wurde die Reprogrammierung dieser epigenetisch und 
funktionell unterschiedlichen Chromatinmodifikationen nach dem Kerntransfer in 
enukleierte Eizellen analysiert. Zudem wurde untersucht, ob die Histon-
methylierungsmuster mit der Entwicklungskapazität der Kerntransferembryonen 
korrelieren. Schließlich wurden Kerntransferembryonen aus MSCs auch auf 
Embfängertiere übertragen, um zu testen, ob sie sich zu lebenden Nachkommen 
entwickeln können.  
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MSC 93 und 95 zeigten nach dem Kerntransfer eine Tendenz zu unterschiedlichen 
Blastozystenraten (29% bzw. 44%), während für die beiden RAF Zellkulturen 
ähnliche Blastozystenraten erhalten wurden (46% bzw. 50%). Kerntransferembryonen 
aus frischen bzw. kryokonservierten MSC A/B entwickelten sich zu einem signifikant 
höheren bzw. ähnlichen Prozentsatz (76% bzw. 45%) zu Blastozysten wie die 
Klonembryonen aus den anderen Zelllinien. Der Tansfer von 404 Kerntransfer-
embryonen aus den MSC Linien R3 und R8 in 10 Empfängertiere resultierte in 5 
Trächtigkeiten und einem geborenen Nachkommen, der nur für wenige Stunden lebte. 
Weder der Transfer von Embryonen im Einzellstadium noch der Kotransfer mit 
parthenogenetischen Embryonen verbesserten die Trächtigkeitsrate bzw. die Ausbeute 
an Nachkommen. Der Transfer von 357 Kerntransferembryonen aus der Linie MSC 
A/B in 10 Empfängertiere resultierte in 4 Trächtigkeiten sowie in der Geburt eines 
geklonten Nachkommen, der drei Tage lebte. Die übrigen 3 Empfängertiere wurden 
am Tag 13 nach dem Embryotransfer geschlachtet. In den Uteri fanden sich insgesamt 
9 Implantationsstellen.  
H3K27m3 war in in vivo Embryonen vom Zygoten- zum Morulastadium nicht 
nachweisbar. Lediglich in einigen Blastozysten zeigten einige Blastomeren eine 
schwache Färbung einer einzelnen Domäne, bei der es sich vermutlich um das 
inaktivierte X-Chromosom handelte. In allen Stadien der Kerntranferembryonen, mit 
Ausnahme des Einzellstadiums und der Blastozyste, war ebenfalls kein H3K27m3 
nachweisbar. Offenbar wurde H3K27m3 in den transferierten Kernen aller 
Spenderzelltypen bis auf kleine Unterschiede im Einzell- und Blastozystenstadium 
korrekt reprogrammiert. Für H3K4m2/3 wurden starke Signale in in vivo-Embryonen 
im Ein- bis Zweizellstadium detektiert, die zum Vierzellstadium leicht und dann 
stärker abnahmen, um im Achtzellstadium einen Tiefpunkt zu erreichen. Im 
Sechzehnzellstadium stieg die Markierung dann wieder an und erreicht schließlich im 
Morula und Blastozystenstadium ähnliche Intensitäten, wie sie im Ein- und 
Zweizellstadium zu beobachten waren. In Kerntransferembryonen aller 
Spenderzelltypen unterschied sich das Fluoreszenzmuster von dem der in vivo 
Embryonen. So wurde das Minimum der Markierung nicht im Acht-, sondern bereits 
im Vierzellstadium erreicht. Die Reprogrammierung der H3K4m2/3 Modifikation 
unterschied sich unabhängig von der verwendeten Spenderzelllinie deutlich zwischen 
den Kerntransferembryonen und den in vivo erzeugten Embryonen. MSC A/B-
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Kerntransferembryonen unterschieden sich von allen anderen dadurch, dass die  
H3K4m2/3 Markierung generell schwächer war und im Bereich der Markierung der 
Kernspenderzellen blieb. Dies weist darauf hin, dass die Reprogrammierung der 
H3K4m2/3 Modifikation in den MSC A/B Zellen weniger ausgeprägt als bei den 
anderen Spenderzellen verlief. Trotzdem entwickelte sich aus den MSC A/B Zellen 
nach dem Kerntransfer ein ähnlicher, teilweise sogar höherer Anteil der Embryonen 
zu Blastozysten als bei den anderen Spenderzellen. Dies weist darauf hin, dass die 
Reprogrammierung der H3K4m2/3 Modifikation nicht unbedingt mit dem 
Entwicklungspotential der Kernspenderzellen korreliert.  
Zusammenfassend zeigt diese Studie, dass Histonmodifikationen, die für 
Heterochromatin charakteristisch sind, nach dem Kerntransfer somatischer Zellen 
beim Kaninchen korrekt reprogrammiert werden, während sich die Muster von 
euchromatischen Histonmodifikationen zwischen den Spenderzelllinien stark 
unterscheiden können und nicht mit der Entwicklungskapazität korrelieren. Obwohl 
die MSCs den RAFs nach den in dieser Studie untersuchten Parametern den RAFs als 
Kernspenderzellen nicht überlegen waren, könnten sie für die Erzeugung transgener 
geklonter Kaninchen aufgrund ihrer höheren Entwicklungsplastizität besser geeignet 
sein. 
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